<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/415208</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Evolutionary Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Competing paths over fitness valleys in growing populations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nicholson</surname><given-names>Michael D.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Antal</surname><given-names>Tibor</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<aff id="a1"><label>1</label><institution>School of Physics and Astronomy, University of Edinburgh</institution>21142 <email>mdnicholson5@gmail.com</email></aff>
<aff id="a2"><label>2</label><institution>School of Mathematics, University of Edinburgh</institution> <email>Tibor.Antal@ed.ac.uk</email></aff>
</contrib-group>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>415208</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="415208.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Investigating the emergence of a particular cell type is a recurring theme in models of growing cellular populations. The evolution of resistance to therapy is a classic example. Common questions are: when does the cell type first occur, and via which sequence of steps is it most likely to emerge? For growing populations, these questions can be formulated in a general framework of branching processes spreading through a graph from a root to a target vertex. Cells have a particular fitness value on each vertex and can transition along edges at specific rates. Vertices represents cell states, say phenotypes or physical locations, while possible transitions are acquiring a mutation or cell migration. We focus on the setting where cells at the root vertex have the highest fitness and transition rates are small. Simple formulas are derived for the time to reach the target vertex and for the probability that it is reached along a given path in the graph. We demonstrate our results on several applications which include: the orderings of resistance-conferring mutations in bacteria and the impact of imperfect drug penetration in cancer.</p>
</abstract>
<counts>
<page-count count="32"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<label>1</label>
<title>Introduction</title>
<p>The timing and manner in which a particular phenotype arises in a population is a central question of theoretical biology [<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c3">3</xref>, <xref ref-type="bibr" rid="c54">54</xref>, <xref ref-type="bibr" rid="c55">55</xref>, <xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c58">58</xref>, <xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c43">43</xref>, <xref ref-type="bibr" rid="c41">41</xref>]. A typical scenario is to consider an initially monomorphic, wild type population, composed of cells that can acquire mutations, for example single site substitutions on the genome. The phenotype of interest comes to exist after a cell has accrued a specific set of mutations. The interpretations of this event are application dependent, but examples are the genesis of cancer instigated by mutations in a pair of tumour suppressor genes, or the emergence of multidrug resistance via alterations to the genes coding for the target proteins. Regardless of context, the questions of when, and how, the phenotype emerges are of significant interest.</p>
<p>Classically, the population under consideration has been assumed to be of a fixed size. However, with the aim of characterising disease progression, an increasing body of research has been developed to examine the evolutionary dynamics of a growing population. These studies have provided insights on a range of applications, including; cancer genetics [<xref ref-type="bibr" rid="c57">57</xref>, <xref ref-type="bibr" rid="c6">6</xref>, <xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c21">21</xref>], metastasis formation [<xref ref-type="bibr" rid="c26">26</xref>, <xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c42">42</xref>, <xref ref-type="bibr" rid="c14">14</xref>], drug resistance [<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c35">35</xref>, <xref ref-type="bibr" rid="c19">19</xref>], phylogenetics [<xref ref-type="bibr" rid="c56">56</xref>], and the impact of poor drug penetration [<xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c40">40</xref>].</p>
<p>Here we continue in the same vein by considering a stochastically growing cellular population, where cells can transition in such a fashion as to alter their, and their offsprings, reproductive capabilities. Such a transition might be the due to the acquisition of a (epi)genetic alteration or migration into a new environment. As before, suppose we have a cellular state of interest, for example; a given genotype, a spatial location, or a combination of both. Will this state ever be reached? If it is, when is it reached? And by which sequence of intermediate states?</p>
<p>To make the discussion clear, let us consider an example application: the emergence of multidrug resistant bacteria. Suppose an infection begins with a single pathogenic bacterium which is sensitive to two antibiotic therapies, drug <italic>A</italic> and drug <italic>B</italic>. In the absence of either drug, the initial bacterium initiates a growing colony. Within the colony, when a cell replicates one of the daughter cells can acquire a mutation yielding resistance to either of the drugs. Here our questions are: how long does it take for multidrug resistance to emerge? En route, is resistance to drug <italic>A</italic> or drug <italic>B</italic> more likely to arise first? The scenario is illustrated in <xref rid="fig1" ref-type="fig">Fig. 1a</xref>. There each vertex represents a cellular type, in this case its resistance profile. The edges represent cell transitions via mutation upon replication.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><p>(a) Motivating example: consider a population of growing drug sensitive bacteria. Each vertex represents a cell type and cells can mutate to acquire resistance. Starting from one sensitive bacterium that can replicate, die or mutate, how long does it take to traverse the graph until multidrug resistance emerges? Is resistance to drug <italic>A</italic> then <italic>B</italic> more likely than the converse? (b) For the general case, the growing population is comprised of different cell types that can be associated to vertices on a graph. Cells at vertex <italic>x</italic> can transition to vertex <italic>y</italic> if the edge (<italic>x, y</italic>) exists. Starting with cells at the root vertex, how long until the target is populated? Is the blue or red path more likely to initiate the target population? Here <italic>N</italic> = 8.</p></caption>
<graphic xlink:href="415208_fig1.tif"/>
</fig>
<p>In this article, motivated by resistance costs and migrated cells exposed to toxins, we focus on the setting where the intermediate states have reduced reproductive ability (fitness) relative to the initial cells. As in many biological applications the relevant transition rates are small (recent measurements for the point mutation rate per cell division are 10<sup>-9</sup> for cancer [<xref ref-type="bibr" rid="c50">50</xref>] and 10<sup>-10</sup> for bacteria [<xref ref-type="bibr" rid="c37">37</xref>], while the dissemination rate of pancreatic cancer cells from the primary tumour was estimated as 10<sup>-7</sup> per cell division in [<xref ref-type="bibr" rid="c25">25</xref>]), we concentrate our efforts on the regime of low transition rates. Our main contribution is to provide simple, intuitive formulas that answer the questions posed in the small transition rate limit. These formulas show explicitly the contribution of the model parameters, e.g. transition rates and fitness reductions, which allow them to be probed for biological insight. This provides relationships which would be difficult to deduce from simulation alone.</p>
<p>We now move to detail the general framework we study, which will be seen to encompass models introduced in previous works as special cases. Our main results concerning when and how a particular cell type emerges are then presented, and we follow this by demonstrating our method on several applications.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Results</title>
<sec id="s2a">
<label>2.1</label>
<title>General framework</title>
<p>Our interest will always be in the emergence of a particular cell type in a growing population which is modelled as a specific form of a multitype branching process [<xref ref-type="bibr" rid="c2">2</xref>]. It is convenient to picture the population on a finite, simple, directed graph <italic>G</italic> = (<italic>V, E</italic>), see <xref rid="fig1" ref-type="fig">Fig. 1b</xref>, where each vertex of the graph represents a cell type or state. The number of types in the system is denoted <italic>N</italic> and so we let <italic>V</italic> = {1, 2, &#x2026;, <italic>N</italic>}. Thus <italic>E</italic> is a subset the set of ordered pairs {(<italic>i, j</italic>): <italic>i, j</italic> &#x2208;<italic>V, i</italic> &#x2260; <italic>j</italic>}. For any given cell type there is an associated vertex in <italic>V</italic>. Henceforth we will refer to cells of type <italic>x</italic> as cells residing at vertex <italic>x</italic>. We will be concerned with the timing, and fashion, that vertex <italic>N</italic>, which we refer to as the target, is populated, when we initiate with cells at vertex 1, which we denote the root. In the example of multidrug resistance, illustrated in <xref rid="fig1" ref-type="fig">Fig. 1a</xref>, the cells at the root are sensitive bacteria while the target population is resistant to both drugs.</p>
<p>Let (<italic>x</italic>) represent a cell at vertex <italic>x</italic> and &#x2205; symbolise a dead cell. Then, with all cells behaving independently, our cell level dynamics can be graphically represented as:
<disp-formula id="ueqn1">
<alternatives><graphic xlink:href="415208_ueqn1.gif"/></alternatives>
</disp-formula></p>
<p>That is: cells give birth at rate <italic>&#x03B1;</italic>(<italic>x</italic>), die at rate <italic>&#x03B2;</italic>(<italic>x</italic>), and transition (at replication) to a cell at vertex <italic>y</italic> at rate <italic>&#x03BD;</italic>(<italic>x, y</italic>) if the edge (<italic>x, y</italic>) exists. We will denote the growth rate of cells at vertex <italic>x</italic> by <italic>&#x03BB;</italic>(<italic>x</italic>) = <italic>&#x03B1;</italic>(<italic>x</italic>) -<italic>&#x03B2;</italic>(<italic>x</italic>). The parameters associated with the vertex 1 population feature prominently and so for convenience we let <italic>&#x03B1;</italic> = <italic>&#x03B1;</italic>(1), <italic>&#x03B2;</italic> = <italic>&#x03B2;</italic>(1) and <italic>&#x03BB;</italic> = <italic>&#x03BB;</italic>(1). As mentioned above, in this article we focus on the setting where the vertex 1 population is the most fit and has positive growth rate. That is, we assume that <italic>&#x03BB;</italic> &#x003E; 0 and for 2 &#x2264; <italic>x</italic> &#x2264; <italic>N</italic> &#x2212; 1, <italic>&#x03BB;</italic>(<italic>x</italic>) &#x003C; <italic>&#x03BB;</italic>. We do not specify the fitness of the target population (cells at vertex <italic>N</italic>). As the model is currently formulated, transitioned cells have deterministically fixed new birth and death rates. However including a finite distribution of fitness effects, for example the scenario that when a cell at vertex <italic>x</italic> transitions it has new birth or death rates with given probabilities, is actually covered by our model as stated. We discuss this point further in <xref ref-type="sec" rid="s2d">Section 2.4</xref>.</p>
<p>At a population level, the number of cells at vertex <italic>x</italic> at time <italic>t</italic> will be denoted <italic>Z</italic><sub><italic>x</italic></sub>(<italic>t</italic>). We shall always assume that the system is initiated with only vertex 1 cells, at a quantity <italic>z</italic>, i.e. <italic>Z</italic><sub><italic>x</italic></sub>(0) = <italic>z&#x03B4;</italic><sub><italic>x</italic>,1</sub> with the Kronecker delta function <italic>&#x03B4;</italic><sub><italic>x,y</italic></sub>.</p>
<p>We have two primary questions. The first is, having initiated the system with <italic>z</italic> vertex 1 cells, how long does it take for the population at the target vertex to arise? That is we concern ourself with the distribution of the target hitting time, defined as
<disp-formula id="eqn1">
<alternatives><graphic xlink:href="415208_eqn1.gif"/></alternatives>
</disp-formula></p>
<p>Now assuming that the target vertex is populated by a founding cell, we ask from which path through the graph <italic>G</italic> did this founding cell come? This gives rise to a distribution over the set of paths (or walks) from the root vertex to the target vertex, which we aim to characterise. This second question is more precisely formulated in <xref ref-type="sec" rid="s2c">Section 2.3</xref>.</p>
<p>Our results are most clearly understood when <italic>G</italic> is acyclic, which amounts to excluding reverse transitions. Therefore in the following presentation this will be assumed. The setting when this assumption is relaxed will be discussed in <xref ref-type="sec" rid="s2d">Section 2.4</xref>.</p>
<p>Consider any path from the root to the target vertex. Intuitively, if the transition rates encountered along this path are larger, the target population will be seeded from this path quicker. Conversely, the smaller the growth rates along this path are, the slower the target will be reached. It will transpire that both the time to the target, and which path is taken, depends on these competing factors through the path weights which we now introduce.</p>
<p>Let the set of paths between the root and the target be be denoted <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub>. Any <italic>p</italic> &#x2208; <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub>, will be a sequence <italic>p</italic> = (<italic>p</italic><sub>1</sub>, <italic>p</italic><sub>2</sub>, &#x2026;, <italic>p</italic><sub><italic>l</italic></sub>, <italic>p</italic><sub><italic>l</italic>&#x002B;1</sub>), where each 1&#x2264; <italic>p</italic><sub><italic>i</italic></sub> &#x2264; <italic>N, l</italic> is the path length (the number of edges in <italic>p</italic>), all <italic>p</italic><sub><italic>i</italic></sub> are distinct, and <italic>p</italic><sub>1</sub> = 1, <italic>p</italic><sub><italic>l</italic>&#x002B;1</sub> = <italic>N</italic>. Along the path <italic>p</italic>, let us call the difference between the growth rate at the root and the vertices encountered the fitness costs. Then we define the weight of the path <italic>w</italic>(<italic>p</italic>) as
<disp-formula id="eqn2">
<alternatives><graphic xlink:href="415208_eqn2.gif"/></alternatives>
</disp-formula>
that is the product of the transition rates along the path divided by the fitness costs along the path. Throughout the empty product is set to 1. Further, we let the total weight of the target be
<disp-formula id="ueqn2">
<alternatives><graphic xlink:href="415208_ueqn2.gif"/></alternatives>
</disp-formula></p>
<p>We will take the case of a path graph as a running example. A path graph, as illustrated in <xref rid="fig2" ref-type="fig">Fig. 2</xref>, is the scenario in which the only edges are (<italic>i, i</italic> &#x002B; 1), for 1 &#x2264;<italic>i</italic> &#x2264;<italic>N</italic> &#x2212;1. There is only one path between the root and the target, say <italic>p</italic><sup>&#x002A;</sup>, and so in this case, <inline-formula><alternatives><inline-graphic xlink:href="415208_inline1.gif"/></alternatives></inline-formula>.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><p>A path graph of length 3, with <italic>N</italic> = 4</p></caption>
<graphic xlink:href="415208_fig2.tif"/>
</fig>
</sec>
<sec id="s2b">
<label>2.2</label>
<title>Time until target vertex is populated</title>
<p>How long do we wait until the target vertex is populated? We answer this question by characterising the distribution of <italic>T</italic>, defined in (1), when the target seeding transition rates (the transition rates associated with edges into the target vertex) are small. The key tool required is the long-time population numbers at the initial and intermediate vertices, which is discussed further in <xref ref-type="sec" rid="s4">Section 4</xref>. Using this we are able to prove the following theorem regarding the target hitting time.</p>
<statement id="stat1">
<label>Theorem 1.</label>
<p>As the target seeding transition rates tend to 0, we have
<disp-formula id="eqn3">
<alternatives><graphic xlink:href="415208_eqn3.gif"/></alternatives>
</disp-formula>
where
<disp-formula id="ueqn3">
<alternatives><graphic xlink:href="415208_ueqn3.gif"/></alternatives>
</disp-formula></p>
</statement>
<p>Heuristically, the time until the target is populated is approximately <italic>&#x00B5;</italic> plus some noise, where the distribution of the noise is given by the right hand side of (3). Note that this distribution depends only on parameters associated with vertex 1 cells, while all other parameters of the system are bundled into <italic>&#x00B5;</italic>. For practical purposes the theorem yields the following approximation
<disp-formula id="eqn4">
<alternatives><graphic xlink:href="415208_eqn4.gif"/></alternatives>
</disp-formula>
which is valid if the target seeding transition rates are small. We note that Theorem 1 has similarities with the results given in [<xref ref-type="bibr" rid="c16">16</xref>]. There the authors examined an approximation of the model studied in this paper, specifically in the path graph setting, but with each transition resulting in an increase in fitness to the transitioned cells.</p>
<p>Notice that it is possible that the target is never populated (<italic>T</italic> = &#x221E;). In the supplementary materials (Proposition 1) we show that if the vertex 1 population survives forever then the target hitting time is finite with probability one. Furthermore in many relevant cases, namely a large initial population, low death rate, or small transition rates leaving vertex 1, that the target is eventually populated is essentially equivalent to the vertex 1 population surviving. Using Theorem 3, presented in <xref ref-type="sec" rid="s4">Section 4</xref>, we have an exact expression for the probability that the vertex 1 population survives (by examining when <italic>W</italic> = 0 from Theorem 3). Therefore, this expression gives an approximation for the probability that the target population will ever arise, that is
<disp-formula id="eqn5">
<alternatives><graphic xlink:href="415208_eqn5.gif"/></alternatives>
</disp-formula></p>
<p>This also explains the <italic>&#x03B2;</italic>/<italic>&#x03B1;</italic> term in (4), which arises due to lineages stemming from the initial vertex 1 cells going extinct. The corresponding approximate distribution for the target hitting time, when the vertex 1 population survives is given in the supplementary materials (Eq. (33)).</p>
<p>We now return to consider <italic>&#x00B5;</italic> as given in Theorem 1. In the case of <italic>&#x03B2;</italic> = 0, <italic>z</italic> = 1, it can be easily seen (if we recall <italic>&#x03BB;</italic> = <italic>&#x03B1;</italic> -<italic>&#x03B2;</italic>) that the median of our approximate distribution (4), is exactly <italic>&#x00B5;</italic>. More generally, if we let <italic>t</italic><sub>1/2</sub> be the median time to hit the target, then conditional that the vertex 1 population survives, as the target seeding transition rates tend to 0, we have
<disp-formula id="eqn6">
<alternatives><graphic xlink:href="415208_eqn6.gif"/></alternatives>
</disp-formula></p>
<p>The shift <italic>h</italic>(<italic>z</italic>), whose precise form can be found in the supplementary materials (Corollary (7.2)), has the behaviour
<disp-formula id="eqn7">
<alternatives><graphic xlink:href="415208_eqn7.gif"/></alternatives>
</disp-formula></p>
<p>The shift exists as initiating the system with a larger number of cells at vertex 1, leads to the target being reached faster. In terms of notation <italic>f</italic> &#x223C; <italic>g</italic> means that <italic>f</italic>/<italic>g</italic> &#x2192; 1, when the limit under consideration is taken.</p>
<p>Let us return to the running example of the path graph setting which was introduced at the end of <xref ref-type="sec" rid="s2a">Section 2.1</xref>. With <italic>z</italic> = 1, (6) yields that the median time for the target population to appear is
<disp-formula id="eqn8">
<alternatives><graphic xlink:href="415208_eqn8.gif"/></alternatives>
</disp-formula>
for small <italic>&#x03BD;</italic>(<italic>N</italic> &#x2212; 1, <italic>N</italic>). The first term on the right hand side comes from waiting for the first transition from the vertex 1 population, while the second is due transitions between the remaining vertices. The first term is distinct as the vertex 1 growth is the main cause of stochasticity, as discussed in <xref ref-type="sec" rid="s4">Section 4</xref>. The population growth and target hitting time is illustrated for the path graph case in <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3:</label>
<caption><p>Stochastic simulation in the case of a path graph with 4 vertices, as in <xref ref-type="fig" rid="fig2">Fig. 2</xref>. Joined lines are the results of simulation. Dashed lines are the asymptotic growth of the populations, which follows the functions given immediately above the dashed lines. These functions are a consequence of Theorem 3, which can be found in <xref ref-type="sec" rid="s4">Section 4</xref>. <italic>W</italic> is a random variable whose value will differ between simulations. The expression for the median time for the type 4 population to arise, as given (8), is displayed below the horizontal axis. Simulation parameters: <italic>&#x03B1;</italic> = <italic>&#x03B1;</italic>(2) = <italic>&#x03B1;</italic>(3) = 1, <italic>&#x03B2;</italic> = 0.4, <italic>&#x03B2;</italic>(2) = <italic>&#x03B2;</italic>(3) = 1.3, <italic>&#x03BD;</italic>(1, 2) = <italic>&#x03BD;</italic>(2, 3) = <italic>&#x03BD;</italic>(3, 4) = 0.05, <italic>z</italic> = 1</p></caption>
<graphic xlink:href="415208_fig3.tif"/>
</fig>
</sec>
<sec id="s2c">
<label>2.3</label>
<title>Path distribution</title>
<p>We now move to our second question: which path leads to the target population arising? Our naive expectation is that paths with larger weights will be more likely and this is confirmed. So that we can formulate our question mathematically, we introduce some notation.</p>
<p>To any existing cell, say at vertex <italic>x</italic>, we may define the cell&#x2019;s vertex lineage. This tracks the vertices of cells in the ancestral lineage of the cell under consideration and is a sequence of the form (1, &#x2026;, <italic>x</italic>). For example a cell with vertex lineage (1, 3, 4) is at vertex 4, and descended from a vertex 3 cell, who in turn descended from a vertex 1 cell. Any vertex lineage is a path in <italic>G</italic> and we denote the number of cells with vertex lineage <italic>q</italic> at time <italic>t</italic> as <italic>X</italic>(<italic>q, t</italic>).</p>
<p>Now for any root to target path <italic>p</italic> &#x2208; &#x1D4AB; <sub>1,<italic>N</italic></sub>, that is a path of the form <italic>p</italic> = (1, <italic>p</italic><sub>2</sub>, <italic>p</italic><sub>3</sub>, &#x2026;, <italic>N</italic>), the first time that <italic>p</italic> is traversed can be defined as
<disp-formula id="eqn9">
<alternatives><graphic xlink:href="415208_eqn9.gif"/></alternatives>
</disp-formula></p>
<p>Observe that path <italic>p</italic> populated the target first if <italic>T</italic> (<italic>p</italic>) = <italic>T</italic>. The question of which path initiated the target only makes sense if the target is eventually populated. To ensure that this occurs we condition on a surviving vertex 1 population, and hence let
<disp-formula id="ueqn4">
<alternatives><graphic xlink:href="415208_ueqn4.gif"/></alternatives>
</disp-formula></p>
<p>We can now state the answer to our second question, which is a special case of Theorem 2 presented below. The probability that the target is populated via path <italic>p</italic> is simply the path weight of <italic>p</italic>, suitably normalised, that is
<disp-formula id="eqn10">
<alternatives><graphic xlink:href="415208_eqn10.gif"/></alternatives>
</disp-formula>
for small target seeding transition rates. One may ask not only if a particular path populated the target, but whether the target was initiated from a given set of paths, for an example see <xref ref-type="sec" rid="s3b">Section 3.2</xref>. In this case the probability that the target is populated via a particular set of paths is given by summing the normalised path weights over each path in the set.</p>
<p>If the vertex 1 population avoids extinction then <italic>T</italic> (<italic>p</italic>) will be finite for each root to target path <italic>p</italic>. Therefore instead of only asking which path populated the target first, one might be interested in whether a particular path is traversed significantly faster. For example, does multidrug resistance obtained via one of the paths in <xref rid="fig1" ref-type="fig">Fig. 1a</xref> occur <italic>t</italic> days before resistance from the other path. In order to also consider this case, for a root to target path <italic>p</italic>, we define
<disp-formula id="ueqn5">
<alternatives><graphic xlink:href="415208_ueqn5.gif"/></alternatives>
</disp-formula>
that is the first time the target is reached along any path except <italic>p</italic>.</p>
<p>We can now quantify the probability of reaching the target via path <italic>p</italic> more than <italic>t</italic> time units before any other path. To avoid discussing a technical assumption, which excludes pathological scenarios, the theorem is stated in approximate form. The more precise version can be found in the supplementary material (Theorem 8).</p>
<statement id="stat2">
<label>Theorem 2.</label>
<p>For small target seeding transition rates, and <italic>t</italic> &#x2208; &#x211D;,
<disp-formula id="ueqn6">
<alternatives><graphic xlink:href="415208_ueqn6.gif"/></alternatives>
</disp-formula></p>
</statement>
<p>Note that letting <italic>t</italic> = 0 gives (10). In the running example of a path graph we cannot ask which path seeded the target vertex. However we briefly illustrate the usefulness of the above theorem by considering the question of whether the target vertex is populated via a fitness valley.</p>
<p>Let us consider the case depicted in <xref rid="fig4" ref-type="fig">Fig. 4a</xref> where two paths exist to the target, a direct path and an indirect path. Here <italic>N</italic> = 3, with paths <italic>p</italic><sup>(1)</sup> = (1, 2, 3), <italic>p</italic><sup>(2)</sup> = (1, 3) and <italic>&#x03BD;</italic> = <italic>&#x03BD;</italic>(1, 2) = <italic>&#x03BD;</italic>(2, 3), <italic>&#x03BD;</italic>(1, 3) = <italic>&#x03BD;</italic><sup>2</sup>. Naively it may be expected that as the product of transition rates along both these paths are equal, and the indirect path (<italic>p</italic><sup>(1)</sup>) contains a vertex with a fitness cost, the direct path (<italic>p</italic><sup>(2)</sup>) is more likely. However, for small <italic>&#x03BD;</italic>, Theorem 2 informs us that the target is populated via the indirect path <italic>t</italic> time units before the direct path, with probability
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4:</label>
<caption><p>(a) Crossing valleys can be faster. Despite the red-dashed path containing a fitness valley, the type 3 population is more likely to arise via this path if <italic>&#x03BB;</italic> &#x2212; <italic>&#x03BB;</italic>(2) &#x003C; 1. See (11). (b) Stochastic simulations of system in (a) vs theory (11). Parameters <italic>&#x03B1;</italic> = 0.9, <italic>&#x03B2;</italic> = 0.3, <italic>&#x03BB;</italic> = 0.6, <italic>&#x03B1;</italic>(2) = 0.2, <italic>&#x03B2;</italic>(2) = 0.4, <italic>&#x03BB;</italic>(2) = &#x2212; 0.2, <italic>&#x03BD;</italic> = 0.1, runs = 250.</p></caption>
<graphic xlink:href="415208_fig4.tif"/>
</fig>
<disp-formula id="eqn11">
<alternatives><graphic xlink:href="415208_eqn11.gif"/></alternatives>
</disp-formula>
where <italic>T</italic> <sup>(<italic>i</italic>)</sup> = <italic>T</italic> (<italic>p</italic><sup>(<italic>i</italic>)</sup>). Thus the indirect path is more probable, that is &#x2119; <sub>1</sub>(<italic>T</italic> <sup>(1)</sup> &#x003C; <italic>T</italic> <sup>(2)</sup>) &#x003E; &#x2119; <sub>1</sub>(<italic>T</italic> <sup>(2)</sup> &#x003C; <italic>T</italic> <sup>(1)</sup>), if <italic>&#x03BB;</italic> &#x2212; 1 &#x003C; <italic>&#x03BB;</italic>(2).</p>
<p>Further applications of the results presented thus far will be given in <xref ref-type="sec" rid="s3">Section 3</xref>. Before this, we discuss the case when <italic>G</italic> is cyclic, and some extensions to the initial model for which our results still hold.</p>
</sec>
<sec id="s2d">
<label>2.4</label>
<title>Cyclic graphs, distribution of fitness effects and extensions</title>
<p>In the above exposition we have assumed that <italic>G</italic> is acyclic, that is no path exists which contains cycles. We now briefly summarise how the results are altered if <italic>G</italic> is cyclic, with details given in the supplementary materials. We will however maintain that the root is a source vertex (has no incoming edges) and the target is a sink (has no outgoing edges).</p>
<p>First we introduce the <italic>N</italic> &#x2212; 1 &#x00D7; <italic>N</italic> &#x2212; 1 matrix <italic>A</italic> with entries
<disp-formula id="ueqn7">
<alternatives><graphic xlink:href="415208_ueqn7.gif"/></alternatives>
</disp-formula>
and we denote the largest real eigenvalue of <italic>A</italic> as <italic>&#x03BB;</italic><sup>&#x002A;</sup>.</p>
<p>In order that a modified version of Theorem 1 holds it is required that <italic>&#x03BB;</italic><sup>&#x002A;</sup> = <italic>&#x03BB;</italic> and <italic>&#x03BB;</italic><sup>&#x002A;</sup> is a simple eigenvalue. This condition is guaranteed for acyclic graphs, and will also be satisfied if the transition rates throughout the graph are small enough (see Lemma 5 in the supplementary materials). Assuming this eigenvalue condition, Theorem 1 holds but with <italic>&#x03D5;</italic><sub><italic>N</italic></sub> replaced by summing particular elements of the <italic>&#x03BB;</italic>-associated eigenvector of <italic>A</italic> (see Theorem 7). Theorem 3, which concerns the population growth at the initial and intermediate vertices and is presented below in <xref ref-type="sec" rid="s4">Section 4</xref>, is similarly modified under the same condition (see Theorem 6).</p>
<p>Turning to Theorem 2, we can now consider walks that contain cycles as opposed to only paths in the graph <italic>G</italic>. If we consider a particular set of root to target walks of a finite length, analogously to Theorem 2, we can ask whether the target is reached via one particular walk more than <italic>t</italic> units before any other walk in the specified set. A near identical result to Theorem 2 is obtained (see Proposition 2 in the supplementary materials). However the path weights should now be replaced by the walk weights (defined analogously to the path weight; the product of the transition rates along the walk divided by the fitness costs along the walk). In particular for two given walks of finite length we can still approximate the probability the target population arises via one of the walks versus the other.</p>
<p>For example we can use this to explore when a walk, containing a cycle, will seed the target before a path. Consider the graph and edge parameters displayed in <xref rid="fig5" ref-type="fig">Fig. 5a</xref>. Let <italic>p</italic> = (1, 2, 4) and <italic>&#x03C9;</italic> = (1, 2, 3, 2, 4).</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5:</label>
<caption><p>(a) Walks containing cycles can seed the target. The walk of length 4 that traverses the red edges with transition rate <italic>&#x03BD;</italic><sub>2</sub> can still be faster than the length 2 path. See (12). (b) Incorporating a distribution of fitnesses. Take the path graph from <xref ref-type="fig" rid="fig2">Fig. 2</xref>. Suppose that instead of a fixed <italic>&#x03BB;</italic>(2), after the first transition cells have fitness <italic>&#x03BB;</italic><sub>1</sub>(2) or <italic>&#x03BB;</italic><sub>2</sub>(2) with probabilities <italic>&#x03C0;</italic><sub>2</sub>(1), <italic>&#x03C0;</italic><sub>2</sub>(2), with <italic>&#x03BB;</italic><sub><italic>i</italic></sub>(2) &#x003C; <italic>&#x03BB;</italic>. Then instead of the original path graph, we consider the enlarged graph shown here, where vertex 2 is replaced by two vertices with associated growth rates <italic>&#x03BB;</italic><sub>1</sub>(2), <italic>&#x03BB;</italic><sub>2</sub>(2). The transition rates to these new vertices are <italic>&#x03BD;</italic>(1, 2)<italic>&#x03C0;</italic><sub>2</sub>(<italic>i</italic>), where <italic>&#x03BD;</italic>(1, 2) is the transition rate between vertices 1 and 2 in the original setting. All results can then be applied to the new enlarged graph.</p></caption>
<graphic xlink:href="415208_fig5.tif"/>
</fig>
<p>Despite the extra length, by using the modified Theorem 2, for small <italic>&#x03BD;</italic><sub>1</sub> we see
<disp-formula id="eqn12">
<alternatives><graphic xlink:href="415208_eqn12.gif"/></alternatives>
</disp-formula></p>
<p>Hence the target can be seeded via the walk, if <italic>&#x03BD;</italic><sub>2</sub> is large enough. On the other hand, by using the modified Theorem 2 it can be seen that when all the transition rates are small in the system, the target population will arise from a path and not a walk containing cycles (see Proposition 3) This further justifies our focus on the acyclic case.</p>
<p>Let us now expand on the comments in <xref ref-type="sec" rid="s2a">Section 2.1</xref> where we claimed that having a finite distribution of fitness effects is covered by our model. Suppose we wish to consider cells transitioning from vertex <italic>x</italic> to vertex <italic>y</italic> but require that the new growth rate of cells to be <italic>&#x03BB;</italic><sub><italic>i</italic></sub>(<italic>y</italic>) with probability <italic>&#x03C0;</italic><sub><italic>y</italic></sub>(<italic>i</italic>), where <italic>&#x03C0;</italic><sub><italic>y</italic></sub>(<italic>i</italic>) is a finite distribution and every <italic>&#x03BB;</italic><sub><italic>i</italic></sub>(<italic>y</italic>) &#x003C; <italic>&#x03BB;</italic>. Then we can simply replace the vertex <italic>y</italic> with new vertices associated to each of the <italic>&#x03BB;</italic><sub><italic>i</italic></sub>(<italic>y</italic>) and have cells transition from vertex <italic>x</italic> to the new vertices at rate <italic>&#x03BD;</italic>(<italic>x, y</italic>)<italic>&#x03C0;</italic><sub><italic>y</italic></sub>(<italic>i</italic>). We may freely apply the results of <xref ref-type="sec" rid="s2">Section 2</xref> to the graph containing the new vertices and edges. See <xref rid="fig5" ref-type="fig">figure 5b</xref> for an example.</p>
<p>We have focused on the setting where cells can birth, die or transition, however Theorem 2 would also hold for a slightly more general branching process. Keeping the transition process as it is, we can have a vertex <italic>x</italic> cell giving birth to <italic>j</italic> vertex <italic>x</italic> cells at a rate <italic>&#x03B1;</italic>(<italic>x</italic>)<italic>&#x03C3;</italic><sub><italic>x,j</italic></sub> where for each <italic>x</italic> between 1 and <italic>N</italic> &#x2212; 1, (<italic>&#x03C3;</italic><sub><italic>x,j</italic></sub>)<sub><italic>j&#x2265;</italic>0</sub> is a probability distribution with finite second moment and mean <inline-formula><alternatives><inline-graphic xlink:href="415208_inline2.gif"/></alternatives></inline-formula>. We now have no need for <italic>&#x03B2;</italic>(<italic>x</italic>) as cell death is contained in <italic>&#x03C3;</italic><sub><italic>x</italic>,0</sub>. In this setting if we redefine <inline-formula><alternatives><inline-graphic xlink:href="415208_inline3.gif"/></alternatives></inline-formula> then the path distribution will be unchanged. This is due to the fact that the key result of [<xref ref-type="bibr" rid="c33">33</xref>] used in the proof of Theorem 3 holds then also. This may be relevant to the case of viral dynamics, where an infected cell can release multiple virions upon bursting [<xref ref-type="bibr" rid="c44">44</xref>].</p>
<p>Throughout we have assumed we wait for the first cell of vertex <italic>N</italic> to arise. However it may be that the population founded by the initial cell at the target vertex goes extinct. If instead one wishes to wait for the first &#x2018;successful&#x2019; cell, that is the first cell of at vertex <italic>N</italic> to exist whose progeny survives, then all the results above hold so long as the mapping <italic>&#x03BD;</italic>(<italic>x, N</italic>) &#x21A6; <italic>&#x03BD;</italic>(<italic>x, N</italic>) <italic>&#x03BB;</italic>(<italic>N</italic>)/<italic>&#x03B1;</italic>(<italic>N</italic>) for all target adjacent vertices <italic>x</italic>, is applied. We have also only considered the case where only a single target vertex exists. It may be of interest to consider several target populations, and then ask which of these populations arises first. Generally these populations can be grouped together and the above results will still apply. However if we wait for the target vertices to be founded by &#x2018;successful&#x2019; individuals to arise a minor modification occurs. For example if we have two target vertices labelled <italic>N</italic><sub>1</sub>, <italic>N</italic><sub>2</sub> we should map <italic>&#x03BD;</italic>(<italic>x, N</italic><sub>1</sub>) &#x21A6; <italic>&#x03BD;</italic>(<italic>x, N</italic><sub>1</sub>)<italic>&#x03BB;</italic>(<italic>N</italic><sub>1</sub>)/<italic>&#x03B1;</italic>(<italic>N</italic><sub>1</sub>) for <italic>x</italic> a neighbour of <italic>N</italic><sub>1</sub> and <italic>&#x03BD;</italic>(<italic>y, N</italic><sub>2</sub>) &#x21A6; <italic>&#x03BD;</italic>(<italic>y, N</italic><sub>2</sub>)<italic>&#x03BB;</italic>(<italic>N</italic><sub>2</sub>)/<italic>&#x03B1;</italic>(<italic>N</italic><sub>2</sub>) for <italic>y</italic> a neighbour of <italic>N</italic><sub>2</sub>. Other numbers of target vertices are treated analogously.</p>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Discussion</title>
<p>We now demonstrate how to apply the results of <xref ref-type="sec" rid="s2">Section 2</xref> on some applications.</p>
<p>Firstly we consider the impact of imperfect drug penetration on the emergence of resistance. Two recent publications have explored how resistance spreads in this setting, and have shown that poor penetration can accelerate resistance [<xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c40">40</xref>]. We are able to recover and extend their findings in a rigorous fashion. Next the ordering by which resistance causing mutations accrue is explored, firstly in the setting of cancer and then in bacterial infections. In the case of bacterial infections we explore how the risk of multidrug resistance depends on mutation rates, recovering simulation results in [<xref ref-type="bibr" rid="c19">19</xref>]. We will be investigating these applications with the approximate formulas implied by the previous section, and we now make a remark on these.</p>
<p>The results of <xref ref-type="sec" rid="s2">Section 2</xref> hold when the final transition rates in each path tends to 0. Therefore in this section all transition rates, in particular the mutation and migration rates discussed below, will be taken to be small and statements are to be interpreted as approximations that hold true in this limiting regime. Furthermore, note that the results of <xref ref-type="sec" rid="s2">Section 2</xref> are given for the case when all transition rates between vertices are distinct (the limits are taken only on the target seeding transition rates and not on all rates simultaneously). However below, and in several of the approximate formulas of <xref ref-type="sec" rid="s2">Section 2</xref>, we will take the intermediate rates equal to the final transition rate. The results of this section could be presented with all transition rates distinct, and approximations given for when the final transition rates are small but non-zero. Then the numerical value for intermediate transition rates could be chosen to be equal to the final transition rates, where for the sake of interpretation they should be the same. We have chosen to avoid such a cumbersome presentation.</p>
<sec id="s3a">
<label>3.1</label>
<title>Imperfect drug penetration: monotherapy</title>
<p>Our first two applications concern imperfect drug penetration and so the language introduced here will hold in the next section also.</p>
<p>We consider a pathogenic population, with cancer cells or bacteria as example populations, being treated with one or more drugs with imperfect penetration profiles. The imperfect penetration results in low drug concentration in spatial locations, such that cells in these locations may still proliferate. We term the cumulation of these spatial regions the <italic>sanctuary</italic>. Sanctuaries have been observed in both bacterial infections [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c53">53</xref>] and tumours [<xref ref-type="bibr" rid="c45">45</xref>]. We consider resistance to have arisen when cells with sufficiently many mutations such that all therapies are impotent come to exist in areas where the drugs have penetrated. The possibility of resistance occurring prior to treatment is excluded and we consider only the case when resistance arises from the sanctuary. Further, we do not consider cells acquiring mutations via gene transfer.</p>
<p>Throughout this section and the next we shall be comparing paths comprised of mutation and migration events. Growing cells in the sanctuary will be the vertex 1 cells from <xref ref-type="sec" rid="s2a">Section 2.1</xref> and thus have birth and death rates <italic>&#x03B1;, &#x03B2;</italic>, with growth rate <italic>&#x03BB;</italic>. The lack of exposure to drug motivates <italic>&#x03BB;</italic> &#x003E; 0. We fix the initial number of cells in the sanctuary to be <italic>z</italic>. We shall assume all cells have birth rate <italic>&#x03B1;</italic>. Across all cell types, i.e. regardless of location or drug presence, the per cell mutation and migration rates will be denoted <italic>&#x03BD;</italic> and <italic>m</italic> respectively. We suppose each mutation carries a fitness cost which will be denoted <italic>s</italic>. Resistance costs may not always exist but are well documented and often assumed in viruses, bacteria and cancer [<xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c18">18</xref>]. Migration events bring cells into contact with drugs and each drug invokes an additive fitness cost <italic>d</italic>, unless resistance to the drug has already been acquired.</p>
<p>There are two paths from which resistance might arise. Firstly, upon replication a cell in the sanctuary may produce a mutant able to grow in the presence of the drug. Then a mutated cell in the sanctuary can migrate to the drug compartment. We term this the mutation-migration path. Analogously we have the migration-mutation path which involves a susceptible cell migrating from the sanctuary, from whose progeny a resistant mutant emerges. Due to the fitness cost of resistance the death rate of mutated cells in the sanctuary is increased to <italic>&#x03B2;</italic> &#x002B; <italic>s</italic>, while the death rate of migrated susceptible cells in the drug compartment is <italic>&#x03B2;</italic> &#x002B; <italic>d</italic>, with <italic>s, d</italic> &#x003E; 0.</p>
<p>The first quantity to determine is the probability of escaping resistance, and its dependence on the initial number of cells in the sanctuary. The approximation of (5) shows the probability resistance never occurs decreases exponentially with the initial number of cells in the sanctuary as P(resistance never occurs) &#x2248; (<italic>&#x03B2;</italic>/<italic>&#x03B1;</italic>)<sup><italic>z</italic></sup>. For the rest of the discussion we will assume resistance does occur. Further we suppose <italic>z</italic> &#x226B; 1, so that we may use the approximate form for <italic>h</italic>(<italic>z</italic>) given in (7). The case when <italic>z</italic> is small could be treated similarly using the exact expression for <italic>h</italic>(<italic>z</italic>).</p>
<p>We now ask when, and via which path, will resistant cells come to exist in the drug compartment? From <xref ref-type="sec" rid="s2">Section 2</xref> we know the key quantities required to answer these questions are the path weights. For this system these are given by
<disp-formula id="ueqn8">
<alternatives><graphic xlink:href="415208_ueqn8.gif"/></alternatives>
</disp-formula></p>
<p>If we now let <italic>t</italic><sub>1/2</sub> be the median time resistance occurs, then using the path weights with (6), we immediately have
<disp-formula id="eqn13">
<alternatives><graphic xlink:href="415208_eqn13.gif"/></alternatives>
</disp-formula></p>
<p>Of note is that the sanctuary size, mutation and migration rate all have equivalent impact. This simple result can now be explored under different biological scenarios.</p>
<p>For example, suppose we are currently using drug A with fitness cost <italic>d</italic><sup>(<italic>A</italic>)</sup> and penetration profile leaving <italic>z</italic><sup>(<italic>A</italic>)</sup> initial cells in the sanctuary. We consider instead using a second drug which results in sanctuary size <italic>z</italic><sup>(<italic>B</italic>)</sup> and has fitness cost <italic>d</italic><sup>(<italic>B</italic>)</sup>. Let the median resistance times under the first and second drug be denoted <inline-formula><alternatives><inline-graphic xlink:href="415208_inline4.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="415208_inline5.gif"/></alternatives></inline-formula> respectively. Then, using (13) we see <inline-formula><alternatives><inline-graphic xlink:href="415208_inline6.gif"/></alternatives></inline-formula>, and hence we should switch to drug B, if
<disp-formula id="eqn14">
<alternatives><graphic xlink:href="415208_eqn14.gif"/></alternatives>
</disp-formula></p>
<p>This inequality is illustrated in <xref rid="fig6" ref-type="fig">Fig. 6b</xref>.</p>
<fig id="fig6" position="float" fig-type="figure">
<label>Figure 6:</label>
<caption><p>(a) In the case of monotherapy, there are two paths by which drug resistance cells can arise in the region containing the drug. Horizontal edges represent changes in genotype (gaining resistance) whereas vertical edges represent changes in spatial location. The values of vertices are the fitness cost cells experience in that state. (b) Comparison of two drugs with differing efficacies and penetration profiles using (14). Arrows pertain to characteristics of drug B relative to drug A. Top left and bottom right quadrants illustrate region where drugs are trivially better, i.e. have superior penetration and efficacy. Parameters: <italic>d</italic><sup>(<italic>A</italic>)</sup> = 10<sup>-2</sup>, <italic>s</italic> = 5 &#x00D7; 10<sup>-3</sup>.</p></caption>
<graphic xlink:href="415208_fig6.tif"/>
</fig>
<p>Note as <italic>d</italic><sup>(<italic>B</italic>)</sup> &#x2192; &#x221E;, implying drug B is far more effective, the condition tends to <italic>&#x03B4;</italic><sub><italic>z</italic></sub> &#x003E; (1 &#x002B; <italic>s</italic>/<italic>d</italic><sup>(<italic>A</italic>)</sup>)<sup>&#x2212;1</sup>. This is due to the fact that when <italic>d</italic><sup>(<italic>B</italic>)</sup> is large resistance will always arise via the mutation-migration path (which we show below), so this provides an upper bound to the gain that can be obtained from increasing the drug efficacy. The above is under the assumption resistance will occur but note the probability of no resistance would decrease exponentially with larger sanctuary size.</p>
<p>Having discussed the time resistance will occur we now ask by which of the two paths it will occur. Let <italic>T</italic><sup><italic>&#x03BD;m</italic></sup> be the first time resistance arises via the mutation-migration path and <italic>T</italic><sup><italic>m&#x03BD;</italic></sup> be defined analogously for the migration-mutation path. Then Theorem 2 gives us
<disp-formula id="ueqn9">
<alternatives><graphic xlink:href="415208_ueqn9.gif"/></alternatives>
</disp-formula></p>
<p>Hence resistance arising via the mutation-migration path is more probable, that is the above probability is greater than 1/2, if <italic>d</italic> &#x003E; <italic>s</italic>. As most drugs are designed to at least halt cell growth, while many resistant cell lines can still proliferate, we expect this condition to be satisfied for most drugs.</p>
<p>A similar question was asked in [<xref ref-type="bibr" rid="c20">20</xref>]. There they considered an approximate stochastic process and sought the parameter regime such that <italic>T</italic><sup><italic>m&#x03BD;</italic></sup> stochastically dominated <italic>T</italic><sup><italic>&#x03BD;m</italic></sup> under the approximate process. For the full process considered here, we can ask the same question but on the limit of the centred, in the sense of Theorem 7, resistance times. The resulting condition for stochastic dominance is again <italic>d</italic> &#x003E; <italic>s</italic>. The difference in the condition given here (<italic>d</italic> &#x003E; <italic>s</italic>) and that stated in equation (28) in [<xref ref-type="bibr" rid="c20">20</xref>] exists as there <italic>&#x03BD;</italic> is defined as the probability of mutation per birth event. Accounting for this leads to the same condition.</p>
</sec>
<sec id="s3b">
<label>3.2</label>
<title>Imperfect penetration: combination therapy</title>
<p>There are at least two reasons for extending our analysis to include two drugs, say drugs <italic>A</italic> and <italic>B</italic>, being used in tandem. Firstly, combination therapies are widely implemented in HIV and bacterial infections, and there is a growing appreciation for their use in cancer [<xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c47">47</xref>, <xref ref-type="bibr" rid="c7">7</xref>]. Secondly, interesting new phenomena emerges, especially when a region still exists with only one drug present.</p>
<p>We will only consider the case where the penetration profile for drug <italic>B</italic> is a subset of drug <italic>A</italic>, and thus a single drug region exists only for drug <italic>A</italic>. This allows us to clearly demonstrate the impact of unequal penetration profiles. In this setting there are 12 possible states that a cell may inhabit, defined by which of the drugs the cell is exposed to and the resistance profile it has obtained. These states are illustrated in <xref rid="fig7" ref-type="fig">Fig. 7a</xref>. We further assume that the mutation rate bringing resistance to either drug is <italic>&#x03BD;</italic>. This is for simplicity only, and dealing with differing mutation rates is straightforward. Drug interactions and epistasis are also neglected but can be included.</p>
<fig id="fig7" position="float" fig-type="figure">
<label>Figure 7:</label>
<caption><p>(a) Illustration of the paths to multidrug resistant cells arising in the region containing both drugs <italic>A</italic> and <italic>B</italic>, as in <xref ref-type="fig" rid="fig6">Fig. 6a</xref>. Note a spatial location exists containing only drug <italic>A</italic>. (b) Exploration of the median time to resistance as the relative size of the region containing only drug <italic>A</italic> to the sanctuary increases. A single drug region can speed up resistance when (15) holds. When true, resistance is fastest at <italic>n</italic><sub>D</sub>/<italic>n</italic><sub>S</sub> &#x2248; 0.6, agreeing with (16). Parameters; (top) <italic>&#x03BD;</italic> = 10<sup>-6</sup>, <italic>m</italic> = 0.05, <italic>d</italic> = 0.9, <italic>s</italic> = 10<sup>-3</sup>, <italic>&#x03BB;</italic> = 0.4, <italic>&#x03B1;</italic> = 0.3, <italic>n</italic><sub>Tot</sub> = 10<sup>7</sup>, <italic>n</italic><sub>DD</sub> = 0.9<italic>n</italic><sub>Tot</sub>, <italic>&#x03B3;</italic> = 10<sup>-3</sup>; (bottom) all same except <italic>s</italic> = 10<sup>-2</sup>.</p></caption>
<graphic xlink:href="415208_fig7.tif"/>
</fig>
<p>To investigate the effect of the single drug region, we introduce further notation. Let <italic>n</italic><sub>Tot</sub> be the number of cells that may reside in our system of interest (e.g. the entire patient or tumour) in the absence of drug. Further, let the regions where both drugs act, the single drug (drug A) acts and the sanctuary have their respective cell capacities denoted by <italic>n</italic><sub>DD</sub>, <italic>n</italic><sub>D</sub>, and <italic>n</italic><sub>S</sub>. We assume that all these capacities are large, and hence we may still investigate the system with our branching process model. These capacities enter the dynamics of the process in the following manner. When a cell leaves the region it is in, at rate <italic>m</italic>, it now may migrate to one of two regions. Of these two regions, we specify that it migrates to a particular region at a frequency proportional to the regions capacity. For example a cell in the sanctuary migrates to the double drug region at rate <italic>mn</italic><sub>DD</sub>/(<italic>n</italic><sub>D</sub> &#x002B; <italic>n</italic><sub>DD</sub>). Resistance mutations and the presence of the drug has the same additive effect as in <xref ref-type="sec" rid="s3a">Section 3.1</xref>.</p>
<p>Observe that there are 18 possible paths by which sensitive cells in the sanctuary can eventually produce fully drug resistant cells in the double drug compartment. To see this it is convenient to separate the paths into those that pass through the single drug compartment, which following [<xref ref-type="bibr" rid="c40">40</xref>] we term stepwise evolution, and those that involve migration from the sanctuary directly to the double drug compartment, which we collectively call direct evolution. For the direct evolution paths there are three transitions needed, mutations yielding resistance to drug <italic>A</italic> and <italic>B</italic> and then the migration to the double drug region. From the number of permutations of these events, this yields 6 direct evolution paths. In the stepwise evolution case four transitions are needed, both mutations and then the two requisite migration events. Notice that the migration from the sanctuary to the single drug region must precede the migration from the single drug region to the double drug region. This leads to 12 stepwise evolution paths. An exemplar stepwise evolution path is a mutation to drug <italic>A</italic>, followed by migration to the single drug region, then a mutation to drug <italic>B</italic>, and finally a migration to the double drug region. The edges of this path are red and dashed in <xref rid="fig7" ref-type="fig">Fig. 7a</xref>.</p>
<p>If the penetration of the drugs increase, then this will result in a reduced initial number of proliferating sanctuary cells, leading to a delay in resistance. However the effect of unequal penetration profiles opens up multiple new paths to resistance which we expect to accelerate the time until fully resistant cells exist in the double drug compartment. Hence a trade-off may exist. To study this we fix <italic>n</italic><sub>Tot</sub> = <italic>n</italic><sub>S</sub>&#x002B;<italic>n</italic><sub>D</sub>&#x002B;<italic>n</italic><sub>DD</sub> and specify that the initial number of cells in the sanctuary is related to its size via <italic>z</italic> = <italic>&#x03B3;n</italic><sub>S</sub> with 0 &#x003C; <italic>&#x03B3;</italic> &#x226A; 1. Further let <italic>t</italic><sub>1/2</sub>(<italic>n</italic><sub>D</sub>/<italic>n</italic><sub>S</sub>) be the median time to resistance with fixed <italic>n</italic><sub>D</sub>/<italic>n</italic><sub>S</sub>. Using the approximation provided by (6) we can explore the behaviour of <italic>t</italic><sub>1/2</sub>(<italic>n</italic><sub>D</sub>/<italic>n</italic><sub>S</sub>). As can be seen in <xref rid="fig7" ref-type="fig">Fig. 7b</xref> it is possible that the existence of the single drug compartment speeds up resistance. We now seek the conditions under which this is the case.</p>
<p>As mentioned previously, it is reasonable to expect the efficacy of either drug is greater than the cost to resistance. Also we may hope that both drugs penetrate the majority of the target system. This motivates taking <italic>s</italic> &#x226A; <italic>d</italic> and (<italic>n</italic><sub>S</sub> &#x002B; <italic>n</italic><sub>D</sub>) &#x226A; <italic>n</italic><sub>Tot</sub>. Under this limit, by examining the sign of <inline-formula><alternatives><inline-graphic xlink:href="415208_inline7.gif"/></alternatives></inline-formula>, we find a simple condition for when increasing the single drug compartment speeds up resistance, namely
<disp-formula id="eqn15">
<alternatives><graphic xlink:href="415208_eqn15.gif"/></alternatives>
</disp-formula></p>
<p>However, when (15) holds, as <italic>n</italic><sub>D</sub>/<italic>n</italic><sub>S</sub> increases eventually a minimal resistance time is achieved. This represents a worse case scenario yielding fastest possible resistance. For <italic>s</italic> &#x226A; <italic>d</italic>, this minimal time occurs when
<disp-formula id="eqn16">
<alternatives><graphic xlink:href="415208_eqn16.gif"/></alternatives>
</disp-formula></p>
<p>We now examine whether resistance arises via stepwise evolution or direct evolution. Let <italic>T</italic> <sup>SE</sup> be the first time resistance occurs via stepwise evolution, and <italic>T</italic> <sup>DE</sup> defined analogously for direct evolution. Then using Theorem 2, again with <italic>s</italic> &#x226A; <italic>d</italic>, we find
<disp-formula id="eqn17">
<alternatives><graphic xlink:href="415208_eqn17.gif"/></alternatives>
</disp-formula></p>
<p>Therefore the larger the proportional size of the single drug region, the more likely resistance will arise via stepwise evolution. A qualitatively similar result was derived in [<xref ref-type="bibr" rid="c40">40</xref>] (e-page 2878) by comparing the most likely stepwise evolution path with the most likely directed evolution path.</p>
<p>Furthermore, in [<xref ref-type="bibr" rid="c40">40</xref>] a minimal resistance time, in the sense of (16), was observed via simulations for the mutation<sub><italic>A</italic></sub>-migration-mutation<sub><italic>B</italic></sub>-migration path (the red and dashed path in <xref rid="fig7" ref-type="fig">Fig. 7a</xref>). Using Theorem 2 we can show that this is the most probable (in the sense of the mode of the path distribution, see (10)) stepwise evolution path whenever <italic>d</italic> &#x003E; <italic>s</italic>. Further, by differentiating the median time along this path, we see a minimal time occurs at <italic>n</italic><sub>D</sub> &#x2248; <italic>n</italic><sub>S</sub>, which recovers the simulation result in [<xref ref-type="bibr" rid="c40">40</xref>] (see their <xref rid="fig3" ref-type="fig">Fig. 3</xref>). That this path is the most probable stepwise evolution path also gives insight into the recurring <italic>s</italic>/<italic>m</italic> term in (15) and (17). Relative to direct evolution this path has an extra migration step, so higher migration should be beneficial. However fitness costs along this paths are incurred only via the cost of resistance, and a smaller <italic>s</italic> diminishes these fitness costs.</p>
</sec>
<sec id="s3c">
<label>3.3</label>
<title>Path to resistance in chronic myeloid leukemia</title>
<p>Let us discuss the example application of [<xref ref-type="bibr" rid="c35">35</xref>], concerning the mechanism by which resistance to the targeted therapy imatinib occurs in chronic myeloid leukemia (CML). The two main resistance mechanisms are via gene amplification of the BCR-ABL fusion gene, which drives the CML, or a point mutation resulting in a modification to the target protein of imatinib. Approximately 100 point mutations have been identified conferring resistance, and a rough estimate for the probability of each of these occurring during a cell division is 10<sup>&#x2212;7</sup> [<xref ref-type="bibr" rid="c36">36</xref>]. Thus the probability of a point mutation conferring resistance is approximately 10<sup>&#x2212;5</sup> per division. The analogous quantity for resistance-causing gene amplifications, in a similar system, was found to be approximately 10<sup>&#x2212;4</sup> [<xref ref-type="bibr" rid="c49">49</xref>]. With the birth rate of leukemic stem cells as <italic>&#x03B1;</italic> = 0.008 day<sup>&#x2212;1</sup> [<xref ref-type="bibr" rid="c39">39</xref>] we have the rate of point mutations as <italic>&#x03BD;</italic><sub><italic>pm</italic></sub> = 8 &#x00D7; 10<sup>&#x2212;8</sup> day<sup>&#x2212;1</sup>, while the rate of resistance due to gene amplifications is <italic>&#x03BD;</italic><sub><italic>ga</italic></sub> = 8 &#x00D7; 10<sup>&#x2212;7</sup> day<sup>&#x2212;1</sup>. Therefore, using this information alone, the probability of resistance arising from a point mutation first is estimated to be 1/11. However, in the majority of cases, the primary mechanism of resistance is found to be point mutations [<xref ref-type="bibr" rid="c5">5</xref>].</p>
<p>Within our framework there are two possible explanations we can explore, both related to the reproductive capabilities of resistant cells. The first is simply that more lineages of amplified cells go extinct. The final paragraph in <xref ref-type="sec" rid="s2d">Section 2.4</xref> indicates how to treat this case. Indeed, if <italic>&#x03C1;</italic><sub><italic>pm</italic></sub> is the average survival probability for a population initiated by a single cell with a point mutation and <italic>&#x03C1;</italic><sub><italic>ga</italic></sub> the analogous quantity for gene amplification, then we find resistance arising first from a point mutation is more probable if <italic>&#x03C1;</italic><sub><italic>pm</italic></sub> &#x003E; 10<italic>&#x03C1;</italic><sub><italic>ga</italic></sub>. This is possible as point mutations may be deleterious or advantageous [<xref ref-type="bibr" rid="c36">36</xref>] whereas gene amplifications appear deleterious [<xref ref-type="bibr" rid="c48">48</xref>].</p>
<p>The second explanation, that suggested in [<xref ref-type="bibr" rid="c35">35</xref>], is that several gene amplifications are required to attain resistance. Suppose a gene amplification increases the death rate of cells by <italic>s</italic> per day. Then if two gene amplifications are required, ignoring the survival probability from before, the probability that resistance arises via point mutation is now
<disp-formula id="ueqn10">
<alternatives><graphic xlink:href="415208_ueqn10.gif"/></alternatives>
</disp-formula></p>
<p>Resistance via points mutations is now more likely if <italic>s</italic> &#x003E; 10<sup>&#x2212;6</sup>. Note that <xref rid="fig4" ref-type="fig">Fig. 4a</xref> serves as a schematic for this scenario, reinterpreting the fitness valley path as resistance arising via gene amplifications and the direct path relating to resistance via point mutations. Further explanations for the primacy of point mutation mediated resistance exist and the assumptions above may not hold. But when they do hold, our results offer a clear framework to investigate such questions.</p>
</sec>
<sec id="s3d">
<label>3.4</label>
<title>Antibacterial multidrug resistance</title>
<p>A timely problem is that posed by the emergence of multidrug resistant bacteria. We now explore some specific examples of our general framework that pertain to this issue. As before we assume resistance occurs a fitness cost and thus the (unmutated) wild-type has the highest growth rate. Using Theorem 2 and measured fitness costs and mutation rates we can predict the most likely path to multidrug resistance.</p>
<p>We consider the acquisition of resistance to both rifampicin and streptomycin in <italic>P</italic>. <italic>aeruginosa</italic>. Recently the fitness costs associated with resistance to rifampicin [<xref ref-type="bibr" rid="c27">27</xref>] and streptomycin [<xref ref-type="bibr" rid="c52">52</xref>] have been reported. Fitness costs were determined by the maximum growth rate of the bacteria undergoing exponential growth on media-rich plates. From [<xref ref-type="bibr" rid="c52">52</xref>] the ratio of streptomycin resistant bacteria to the wild-type&#x2019;s growth rate was 0.71 (here the wild-type&#x2019;s growth rate is estimated to be 5.1 mOD min<sup>&#x2212;1</sup> from <xref rid="fig2" ref-type="fig">Fig. 2</xref>.a in [<xref ref-type="bibr" rid="c52">52</xref>]). The same value for resistance to rifampicin, in [<xref ref-type="bibr" rid="c27">27</xref>], was 0.88. Let <italic>T</italic><sup><italic>RS</italic></sup> be the time when multidrug resistance emerges assuming rifampicin resistance is acquired first, and <italic>T</italic><sup><italic>SR</italic></sup> defined analogously for streptomycin resistance first. Then from Theorem 2, we have that
<disp-formula id="ueqn11">
<alternatives><graphic xlink:href="415208_ueqn11.gif"/></alternatives>
</disp-formula></p>
<p>Hence, under this model, we would predict that rifampicin resistance emerges first en route to multidrug resistance. We note that above we have taken the average fitness costs associated with the differing antibiotics. Fluctuations have not been taken into account.</p>
<p>Instead of considering the the acquisition of resistance to different drugs within a bacterial strain, we can also examine the impact of differing mutation rates across strains. In [<xref ref-type="bibr" rid="c19">19</xref>] the heightened occurrence of multidrug resistance in lineage 2 vs lineage 4 from <italic>M</italic>. <italic>tuberculosis</italic> was investigated. Considering in particular resistance to rifampicin and isoniazid, via simulations they deduced that the heightened occurrence of resistance was due to elevated mutation rates in lineage 2 strains. The model simulated can be considered a discrete time counterpart to ours in the case of two paths of length 2 (see <xref rid="fig1" ref-type="fig">Fig. 1a</xref>). One of the main quantities of interest was the relative probability of resistance, when the only difference between the strains was the mutation rates. For a particular strain, initiated with one wild-type cell with wild-type birth and growth rates, <italic>&#x03B1;, &#x03BB;</italic>, suppose we have mutation rate <italic>&#x03BD;</italic><sub>R</sub>, <italic>&#x03BD;</italic><sub>I</sub> to rifampicin and isoniazid, each incurring the same fitness cost <italic>s</italic>. Then from Theorem 1, we have
<disp-formula id="eqn18">
<alternatives><graphic xlink:href="415208_eqn18.gif"/></alternatives>
</disp-formula></p>
<p>For lineage-<italic>i</italic> (<italic>i</italic> = 2, 4) let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline8.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="415208_inline9.gif"/></alternatives></inline-formula> be the mutation rates to rifampicin and isoniazid. As in [<xref ref-type="bibr" rid="c19">19</xref>], keeping all other parameters equal between the lineages we have the relative probaility of resistance
<disp-formula id="ueqn12">
<alternatives><graphic xlink:href="415208_ueqn12.gif"/></alternatives>
</disp-formula></p>
<p>For times such that <inline-formula><alternatives><inline-graphic xlink:href="415208_inline10.gif"/></alternatives></inline-formula>, we see the relative probability is simply <inline-formula><alternatives><inline-graphic xlink:href="415208_inline11.gif"/></alternatives></inline-formula>. Taking the mutation rates measured in [<xref ref-type="bibr" rid="c19">19</xref>], this gives the relative probability of 22.06. This agrees with the simulation results in [<xref ref-type="bibr" rid="c19">19</xref>] who reported an approximately 22 fold increase. If in (18), we replace the <italic>&#x03BB;</italic><sup>2</sup>/<italic>&#x03B1;</italic> with <italic>&#x03BB;</italic> and <italic>e</italic><sup><italic>&#x03BB;t</italic></sup> with <italic>M</italic>, our expression is the same, to leading order in the mutation rates, as that given in [<xref ref-type="bibr" rid="c10">10</xref>] (<xref ref-type="disp-formula" rid="eqn2">equation 2</xref>) for the probability of resistance in a population of size <italic>M</italic>. This difference between fixed population size and fixed time results is the same as given in [<xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c16">16</xref>].</p>
</sec>
<sec id="s3e">
<label>3.5</label>
<title>Concluding remarks</title>
<p>In this article we have considered a continuous time birth-death process with transitions. The time until a population of a particular target state arises was investigated. This target state is accessible via one or more transitions from the initial population. Which sequence of transitions leads to the target population arising was explored. This gave rise to a probability distribution over the paths composed of transitions between differing vertices. Motivated by applications, the setting when the initial population was most fit was focused on.</p>
<p>The important factor in determining whether the target was reached via a specific path was seen to be the weight of the path. This is comprised of the transition rates and fitness costs associated with the intermediate vertices along the considered path. Both the target hitting time and the distribution of paths to the target have simple explicit formulas for small transition rates. The utility of these formulas was demonstrated on a variety of applications. The biological relations revealed would have been difficult to deduce by a simulation based approach.</p>
<p>Many previous studies have considered the probability of particular cell type emerging in a growing population, typically by a fixed time after the process starts or when the total population reaches a given size. However the majority deal with the target population being one or two transitions away from the initial population (the root vertex in this paper) [<xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c26">26</xref>, <xref ref-type="bibr" rid="c8">8</xref>]. Two notable exceptions are [<xref ref-type="bibr" rid="c35">35</xref>] and [<xref ref-type="bibr" rid="c16">16</xref>]. In [<xref ref-type="bibr" rid="c35">35</xref>], the same model as that presented here is numerically explored when all vertices have the same fitness, and the implications on multidrug therapy failure is emphasised. With the motivation of driver mutations in cancer, [<xref ref-type="bibr" rid="c16">16</xref>] examines an approximation of the model studied in this paper, in the case where each transition leads to a fitness increase.</p>
<p>Justified criticisms have been made on the use of birth-death processes as modelling framework. In particular the potential for unlimited growth and the lack of interactions between the cells is unrealistic. However in systems with large carrying capacities and abundant resources, they provide a convenient approximation and are widely used. Whenever this framework is deemed appropriate, this article provides quick and accessible results which may be used to guide and develop biological insight.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Materials and Methods</title>
<sec id="s4a">
<label>4.1</label>
<title>Population growth</title>
<p>The main ingredient in proving Theorem 1, and consequently Theorem 2, is the long-time behaviour of the population of the initial and intermediate vertices. In this section we discuss this asymptotic behaviour.</p>
<p>Firstly we extend the definition of the total path weight given in <xref ref-type="sec" rid="s2a">Section 2.1</xref>. Let the set of paths between the root and vertex <italic>x</italic> be denoted <italic>&#x1D4AB;</italic><sub>1,<italic>x</italic></sub>. Then using the definition of path weight (2), we let the total weight for vertex <italic>x</italic> be
<disp-formula id="ueqn13">
<alternatives><graphic xlink:href="415208_ueqn13.gif"/></alternatives>
</disp-formula>
for 2 &#x2264;<italic>x</italic> &#x2264;<italic>N</italic>. We further set <italic>&#x03D5;</italic><sub>1</sub> = 1 which will allow us to conveniently describe the growth at vertex 1 also.</p>
<p>The target population can only be founded by transitions from cells residing at the neighbouring vertices (vertices connected to the target by an edge). Therefore, understanding the population growth of cells at these vertices is needed to discuss the timing and manner in which cells at the target arise. At large times, this understanding is provided by the following theorem, concerning the population at the initial and intermediate vertices. It follows from a more general result due to Janson [<xref ref-type="bibr" rid="c33">33</xref>], which we have tailored to our particular setting.</p>
<statement id="stat3">
<label>Theorem 3.</label>
<p>With probability one
<disp-formula id="ueqn14">
<alternatives><graphic xlink:href="415208_ueqn14.gif"/></alternatives>
</disp-formula></p>
<p>Here W is distributed as the sum of K independent exponential random variables with parameter &#x03BB;/&#x03B1;, where K is binomial with z trials and success probability &#x03BB;/&#x03B1;.</p>
</statement>
<p>The distribution of <italic>W</italic> may be called a binomial-Erlang mixture, being an Erlang distribution with a binomially distributed shape parameter. For the running example of a path graph, we see that asymptotically <italic>Z</italic><sub><italic>i</italic>&#x002B;1</sub>(<italic>t</italic>) is related to <italic>Z</italic><sub><italic>i</italic></sub>(<italic>t</italic>) by a multiplicative factor of <inline-formula><alternatives><inline-graphic xlink:href="415208_inline12.gif"/></alternatives></inline-formula>. This is demonstrated in <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p>
<p>Using Theorem 3 and that the immigration rate into the target vertex from any target neighbouring vertex <italic>x</italic> is <italic>Z</italic><sub><italic>x</italic></sub>(<italic>t</italic>)<italic>&#x03BD;</italic>(<italic>x, N</italic>) we are able to prove the results of <xref ref-type="sec" rid="s2">Section 2</xref>. Full proofs are provided in the supplementary materials.</p>
<p><bold>Acknowledgments</bold></p>
<p>We thank David Cheek, Stefano Avanzini and the Edinburgh physics population dynamics group for helpful discussions and feedback. MDN acknowledges support from EPSRC via a studentship.</p>
</sec>
</sec>
<sec id="s5" sec-type="supplementary-material">
<label>5</label>
<title>Supplementary Material</title>
<p>The outline of this supplement is as follows. First we recap the model, introducing notation that will be needed. Next we prove versions of Theorem 3 and Theorem 1, which do not require <italic>G</italic> to be acyclic. After this we specialise to the acyclic case. Staying with the acyclic case we prove Theorem 2. Finally, how the path distribution is altered when cycles are permitted is considered.</p>
<sec id="s5a">
<label>5.1</label>
<title>Model recap</title>
<p>We recap our framework. Our model is a specific form of multitype branching process [<xref ref-type="bibr" rid="c2">2</xref>] in which each population will evolve according to a Markovian linear birth-death process with transitions. We will assume each population is comprised of cells. As a conceptual framework we associate the multitype branching process with a simple, finite, rooted, directed, graph <italic>G</italic> = (<italic>V, E</italic>) containing <italic>N</italic> vertices (<italic>N</italic> = &#x007C;<italic>V</italic> &#x007C;). Labels of the vertices take values in {1, &#x2026;, <italic>N</italic>} and <italic>E</italic> is a subset of the set of ordered pairs {(<italic>i, j</italic>): <italic>i, j</italic> &#x2208; <italic>V, i</italic> &#x2260;<italic>j</italic>}. We shall often refer to vertex 1 as the root and vertex <italic>N</italic> as the target. Each vertex is reachable from the root and the target is reachable from any other vertex. We further assume the root is a source vertex and the target vertex is a sink. Letting the set of incoming neighbours for vertex <italic>i</italic> be <italic>&#x1D4A9;</italic> <sup>&#x2212;</sup>(<italic>i</italic>) = {<italic>k</italic> &#x2208; <italic>V</italic>: (<italic>k, i</italic>) &#x2208; <italic>E</italic>} and the set of outgoing neighbours <italic>&#x1D4A9;</italic> <sup>&#x002B;</sup>(<italic>i</italic>) = {<italic>k</italic> &#x2208; <italic>V</italic>: (<italic>i, k</italic>) &#x2208; <italic>E</italic>}, the previous assumption is <italic>&#x1D4A9;</italic> <sup>&#x2212;</sup>(1) = <italic>&#x1D4A9;</italic> <sup>&#x002B;</sup>(<italic>N</italic>) = <italic>&#x2205;</italic>. Each type in the branching process is uniquely mapped to a vertex, and so the number of types is <italic>N</italic>. Hence any cell may be described by its type or the vertex associated to that type.</p>
<p>Take any cell at vertex <italic>x</italic>. We assume this cell gives birth (replaced by two identical copies) at rate <italic>&#x03B1;</italic>(<italic>x</italic>), dies (removed from system) at rate <italic>&#x03B2;</italic>(<italic>x</italic>) and transitions to a cell at vertex <italic>y</italic> (replaced by an identical copy and a cell at vertex <italic>y</italic>) at rate <italic>&#x03BD;</italic>(<italic>x, y</italic>) if edge (<italic>x, y</italic>) is contained in <italic>E</italic>. The growth rate of cells at vertex <italic>x</italic> will be denoted <italic>&#x03BB;</italic>(<italic>x</italic>) = <italic>&#x03B1;</italic>(<italic>x</italic>) &#x2212; <italic>&#x03B2;</italic>(<italic>x</italic>). The parameters associated with the vertex 1 population feature prominently and so for convenience we let <italic>&#x03B1;</italic> = <italic>&#x03B1;</italic>(1), <italic>&#x03B2;</italic> = <italic>&#x03B2;</italic>(1) and <italic>&#x03BB;</italic> = <italic>&#x03BB;</italic>(1). All cells are independent. We will focus on the setting where the vertex 1 population is the most fit and has positive growth rate. Therefore, we henceforth assume that <italic>&#x03BB;</italic> &#x003E; 0 and for 2 &#x2264; <italic>x</italic> &#x2264; <italic>N</italic> &#x2212; 1, <italic>&#x03BB;</italic>(<italic>x</italic>) &#x003C; <italic>&#x03BB;</italic>. We do not specify the relative fitness of the vertex <italic>N</italic> population. The cell level dynamics may summarised as
<disp-formula id="ueqn15">
<alternatives><graphic xlink:href="415208_ueqn15.gif"/></alternatives>
</disp-formula>
where (<italic>x</italic>) represents a cell at vertex <italic>x</italic> and &#x2205; symbolises a dead cell. At a population level, the number of cells at vertex <italic>x</italic> at time <italic>t</italic> will be denoted <italic>Z</italic><sub><italic>x</italic></sub>(<italic>t</italic>). We shall always assume <italic>Z</italic><sub><italic>x</italic></sub>(0) = <italic>z&#x03B4;</italic><sub><italic>x</italic>,1</sub>, where <italic>&#x03B4;</italic><sub><italic>x,y</italic></sub> is the Kronecker delta function. The population growth of the initial and intermediate vertices is crucial and so the notation <italic>Z</italic>(<italic>t</italic>) = (<italic>Z</italic><sub><italic>x</italic></sub>(<italic>t</italic>))<sub>1&#x2264;<italic>x</italic>&#x2264;<italic>N</italic>-1</sub> will be used.</p>
</sec>
<sec id="s5b">
<label>5.2</label>
<title>Population growth</title>
<p>In this section we prove Theorem 3, but <italic>G</italic> is not assumed to be acyclic. Specialising to the acyclic case is in <xref ref-type="sec" rid="s5d">Section 5.4</xref>.</p>
<p>As the root vertex is a source, and hence no type transitions into vertex 1 cells, <italic>Z</italic><sub>1</sub>(<italic>t</italic>) follows a linear birth-death process. Its asymptotic behaviour is described by the following classic result [<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c15">15</xref>].</p>
<statement id="stat4">
<label>Lemma 4.</label>
<p><disp-formula id="ueqn16">
<alternatives><graphic xlink:href="415208_ueqn16.gif"/></alternatives>
</disp-formula></p>
<p>Here W is distributed as the sum of K independent exponential random variables with parameter &#x03BB;/&#x03B1;, where K is binomial with z trials and success probability &#x03BB;/&#x03B1;.</p></statement>
<p><italic>W</italic>, as given in the above theorem, is positive only when the vertex 1 population survives (almost surely). It will be convenient to define this event and so we let
<disp-formula id="eqn19">
<alternatives><graphic xlink:href="415208_eqn19.gif"/></alternatives>
</disp-formula></p>
<p>From the distribution of <italic>W</italic> we immediately have
<disp-formula id="eqn20">
<alternatives><graphic xlink:href="415208_eqn20.gif"/></alternatives>
</disp-formula></p>
<p>To obtain a similar result to Lemma 4 for <italic>&#x01B6;</italic> (<italic>t</italic>), we recall the <italic>N</italic> &#x2212; 1 &#x00D7; <italic>N</italic> &#x2212; 1 matrix <italic>A</italic> from <xref ref-type="sec" rid="s2d">Section 2.4</xref>, with entries
<disp-formula id="ueqn17">
<alternatives><graphic xlink:href="415208_ueqn17.gif"/></alternatives>
</disp-formula></p>
<p>Note that the off diagonal elements of the transpose of <italic>A</italic> are positive whenever the corresponding element of the adjaceny matrix of <italic>G</italic> is one.</p>
<p>We will be using a result from [<xref ref-type="bibr" rid="c33">33</xref>] which holds when the largest real eigenvalue of <italic>A, &#x03BB;</italic><sup>&#x002A;</sup>, is simple (i.e. has algebraic multiplicity 1) and equal to <italic>&#x03BB;</italic>. Below we give two sufficient conditions for this to be true. The second is motivated by applications when typically all transition rates are small.</p>
<statement id="stat5">
<label>Lemma 5.</label>
<p>Two sufficient conditions such that &#x03BB;<sup>&#x002A;</sup> = &#x03BB; and is simple are: 1) G is acyclic. 2) For all 2 &#x2264; i &#x2264; N &#x2212; 1, &#x03BB;(i) &#x002B; &#x03A3;<sub>k&#x2208; &#x1D4A9; -(i)</sub> &#x03BD;(k, i) &#x003C; &#x03BB;.</p>
<p>Proof. 1) As G is directed and acyclic, a relabelling of the vertices exists (often called the topological sorting, see [<xref ref-type="bibr" rid="c11">11</xref>] chapter 22.4) such that the underlying adjaceny matrix of the relabelled graph is upper triangular. We use this relabelling with vertex 1 as first in the labelling, &#x03C0;. Thus &#x03C0; is a permutation of {1, &#x2026;, N} with &#x03C0;(1) = 1. The permutation matrix associated with &#x03C0; and its transpose are
<disp-formula id="ueqn18">
<alternatives><graphic xlink:href="415208_ueqn18.gif"/></alternatives>
</disp-formula></p>
<p>Under <italic>&#x03C0;</italic> we have the new matrix
<disp-formula id="ueqn19">
<alternatives><graphic xlink:href="415208_ueqn19.gif"/></alternatives>
</disp-formula></p>
<p>Due to the relation between the adjaceny matrix of <italic>G</italic> and <italic>A</italic>, we see <italic>A</italic>&#x2032; is lower triangular and has the <italic>&#x03BB;</italic>(<italic>i</italic>) as diagonal elements. Thus <italic>&#x03BB;</italic> is the largest eigenvalue of <italic>A</italic>&#x2032;. As <italic>A</italic> and <italic>A</italic>&#x2032; are similar matrices, and hence share eigenvalues, we can conclude the statement.</p>
<p>2) By considering the left eigenvector <inline-formula><alternatives><inline-graphic xlink:href="415208_inline13.gif"/></alternatives></inline-formula>, <italic>&#x03BB;</italic> is indeed an eigenvalue. We now demonstrate all other eigenvalues have real part smaller than <italic>&#x03BB;</italic>, which implies <italic>&#x03BB;</italic> is simple. Observe that the assumed condition implies the bound on the row sums
<disp-formula id="eqn21">
<alternatives><graphic xlink:href="415208_eqn21.gif"/></alternatives>
</disp-formula></p>
<p>As <italic>A</italic> is reducible (due to the root being a source vertex) there exists a permutation matrix <italic>P</italic><sub>2</sub> such that
<disp-formula id="ueqn20">
<alternatives><graphic xlink:href="415208_ueqn20.gif"/></alternatives>
</disp-formula>
with each submatrix <italic>R</italic><sub><italic>i,i</italic></sub> square and irreducible and 2 &#x2264; <italic>M</italic> &#x2264; <italic>N</italic> &#x2212; 1 (see [<xref ref-type="bibr" rid="c51">51</xref>] <xref ref-type="sec" rid="s2c">section 2.3</xref>). The eigenvalues of <italic>A</italic> comprise <italic>&#x03BB;</italic> and the eigenvalues of the <italic>R</italic><sub><italic>i,i</italic></sub>. For any of the <italic>R</italic><sub><italic>i,i</italic></sub> let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline14.gif"/></alternatives></inline-formula> be sum of the <italic>j</italic>th row of <italic>R</italic><sub><italic>i,i</italic></sub>. By Gershgorin&#x2019;s Disc Theorem ([<xref ref-type="bibr" rid="c51">51</xref>] Theorem 1.5) the real part of the eigenvalues of <italic>R</italic><sub><italic>i,i</italic></sub> are bounded by <inline-formula><alternatives><inline-graphic xlink:href="415208_inline15.gif"/></alternatives></inline-formula>. Further, the bound (21) is preserved under permutations and so each <inline-formula><alternatives><inline-graphic xlink:href="415208_inline16.gif"/></alternatives></inline-formula>. As this holds for each <italic>R</italic><sub><italic>i,i</italic></sub> the claim is shown.</p>
</statement>
<p>Henceforth we assume either of the conditions given in Lemma 5 hold and thus <italic>&#x03BB;</italic><sup>&#x002A;</sup> = <italic>&#x03BB;</italic> and is simple. Due to this assumption, results of [<xref ref-type="bibr" rid="c33">33</xref>] show that the vertex 1 cells drives the entire population growth. To state this result, we introduce the vector <italic>&#x03C8;</italic> with
<disp-formula id="ueqn21">
<alternatives><graphic xlink:href="415208_ueqn21.gif"/></alternatives>
</disp-formula></p>
<p>Now let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline17.gif"/></alternatives></inline-formula> be the left and right eigenvectors of <italic>A</italic> corresponding to <italic>&#x03BB;</italic>, scaled such that
<disp-formula id="eqn22">
<alternatives><graphic xlink:href="415208_eqn22.gif"/></alternatives>
</disp-formula></p>
<p>Note, from the structure of <italic>A, &#x0169;</italic><sub><italic>i</italic></sub> &#x003E; 0 if <italic>i</italic> = 1 and 0 otherwise. Further let
<disp-formula id="ueqn22">
<alternatives><graphic xlink:href="415208_ueqn22.gif"/></alternatives>
</disp-formula></p>
<p>Then the following result, which is the more general form of Theorem 3, holds.</p>
<statement id="stat6">
<label>Theorem 6.</label>
<p>With W as in Lemma 4,
<disp-formula id="ueqn23">
<alternatives><graphic xlink:href="415208_ueqn23.gif"/></alternatives>
</disp-formula></p>
<p><italic>Proof</italic>. We demonstrate how to apply the result in [<xref ref-type="bibr" rid="c33">33</xref>] to our setting. From Theorem 3.1 in [<xref ref-type="bibr" rid="c33">33</xref>], with probability one
<disp-formula id="ueqn24">
<alternatives><graphic xlink:href="415208_ueqn24.gif"/></alternatives>
</disp-formula>
where <italic>&#x0174;</italic> is a non-negative random variable, with as yet unknown distribution. However from Lemma 4 almost surely <italic>e</italic><sup>&#x2212;<italic>&#x03BB;t</italic></sup><italic>Z</italic><sub>1</sub>(<italic>t</italic>) &#x2192; <italic>W</italic>, with the distribution of <italic>W</italic> given in the lemma. This implies <italic>&#x0174;</italic>=<italic>W</italic>/<italic>&#x0169;</italic><sub>1</sub> = <italic>&#x0169;</italic><sub>1</sub><italic>W</italic> with the last equality following from (22) and that only the first entry of <italic>&#x0169;</italic> is positive.</p></statement>
</sec>
<sec id="s5c">
<label>5.3</label>
<title>Time until target vertex is populated: general case</title>
<p>We now turn our attention to <italic>T</italic>, the time at which the target population arises, as defined in (1). So that we can control all target seeding transition rates we let
<disp-formula id="ueqn25">
<alternatives><graphic xlink:href="415208_ueqn25.gif"/></alternatives>
</disp-formula>
i.e. the largest of the transition rates into the target. We further give the definition of <italic>&#x00B5;</italic> in this more general setting as
<disp-formula id="ueqn26">
<alternatives><graphic xlink:href="415208_ueqn26.gif"/></alternatives>
</disp-formula></p>
<p>Then the following holds.</p>
<statement id="stat7">
<label>Theorem 7.</label>
<p>Let W be as in Theorem 6, then with probability one
<disp-formula id="ueqn27">
<alternatives><graphic xlink:href="415208_ueqn27.gif"/></alternatives>
</disp-formula></p>
<p>It follows that
<disp-formula id="ueqn28">
<alternatives><graphic xlink:href="415208_ueqn28.gif"/></alternatives>
</disp-formula></p>
<p>Proof. Let
<disp-formula id="ueqn29">
<alternatives><graphic xlink:href="415208_ueqn29.gif"/></alternatives>
</disp-formula></p>
<p>Then, as for given (<italic>&#x01B6;</italic> (<italic>t</italic>))<sub><italic>t&#x2265;</italic>0</sub> immigration into vertex <italic>N</italic> occurs as a non-homogeneous Poisson process,
<disp-formula id="eqn23">
<alternatives><graphic xlink:href="415208_eqn23.gif"/></alternatives>
</disp-formula></p>
<p>The variable change <italic>u</italic> = <italic>s</italic> &#x2212; <italic>&#x03BB;</italic><sup>&#x2212;1</sup> log(<italic>&#x03C3;</italic><sup>&#x2212;1</sup>) yields
<disp-formula id="eqn24">
<alternatives><graphic xlink:href="415208_eqn24.gif"/></alternatives>
</disp-formula></p>
<p>Now observe that for any <italic>i</italic> &#x2208; <italic>&#x1D4A9;</italic> <sup>&#x2212;</sup>(<italic>N</italic>), by multiplying by <inline-formula><alternatives><inline-graphic xlink:href="415208_inline21.gif"/></alternatives></inline-formula>,
<disp-formula id="eqn25">
<alternatives><graphic xlink:href="415208_eqn25.gif"/></alternatives>
</disp-formula></p>
<p>Consider the limit of (25) as <italic>&#x03BD;</italic><sup>&#x002A;</sup> &#x2192; 0, which results in log(<italic>&#x03C3;</italic><sup>&#x2212;1</sup>) &#x2192; &#x221E;. As the (<italic>Z</italic><sub><italic>i</italic></sub>(<italic>t</italic>))<sub><italic>i</italic>&#x2208; <italic>&#x1D4A9;</italic></sub>&#x2212;(<italic>N</italic>) are independent of (<italic>&#x03BD;</italic>(<italic>i, N</italic>))<sub><italic>i</italic>&#x2208; <italic>&#x1D4A9;</italic></sub>&#x2212;(<italic>N</italic>), Theorem 6 provides the limit for the first term in the product of each summand. Upon considering (<italic>&#x03C3;</italic>/<italic>&#x03BD;</italic>(<italic>i, N</italic>))<sup>&#x2212;1</sup>, we see <italic>&#x03BD;</italic>(<italic>i, N</italic>)/<italic>&#x03C3;</italic> &#x003C; &#x221E; for each <italic>i</italic>. Hence taking limits across (25) yields, with probability one,
<disp-formula id="ueqn30">
<alternatives><graphic xlink:href="415208_ueqn30.gif"/></alternatives>
</disp-formula></p>
<p>By the definition of <italic>&#x03C3;</italic> this last sum is one and hence
<disp-formula id="eqn26">
<alternatives><graphic xlink:href="415208_eqn26.gif"/></alternatives>
</disp-formula></p>
<p>We seek to apply the dominated convergence theorem to the integral in (24). The above convergence implies that for any realisation, we may find <italic>x</italic> such that for <italic>&#x03BD;</italic><sup>&#x002A;</sup> &#x2264; <italic>x</italic>
<disp-formula id="ueqn31">
<alternatives><graphic xlink:href="415208_ueqn31.gif"/></alternatives>
</disp-formula>
which is integrable over (&#x2212;&#x221E;, <italic>t</italic>]. If <italic>&#x03BD;</italic><sup>&#x002A;</sup> &#x003E; <italic>x</italic> then <italic>&#x03C3;</italic> &#x003E; 0. Thus the interval [<italic>&#x03BB;</italic><sup>&#x2212;1</sup> log(<italic>&#x03C3;</italic><sup>&#x2212;1</sup>), <italic>t</italic>] is finite. As each <italic>Z</italic><sub><italic>i</italic></sub>(<italic>t</italic>) is cadlag, it is bounded over finite intervals. Hence for all (<italic>&#x03BD;</italic><sup>&#x002A;</sup>, <italic>u</italic>) the integrand is dominated by an integrable function. Therefore, taking the limit of (24) and using (26) leads to, with probability one,
<disp-formula id="ueqn32">
<alternatives><graphic xlink:href="415208_ueqn32.gif"/></alternatives>
</disp-formula></p>
<p>Using that
<disp-formula id="ueqn33">
<alternatives><graphic xlink:href="415208_ueqn33.gif"/></alternatives>
</disp-formula>
so that we centre appropriately, leads to the first stated result.</p>
<p>For the second statement, we must derive an expression for
<disp-formula id="ueqn34">
<alternatives><graphic xlink:href="415208_ueqn34.gif"/></alternatives>
</disp-formula></p>
<p>From Lemma 4
<disp-formula id="ueqn35">
<alternatives><graphic xlink:href="415208_ueqn35.gif"/></alternatives>
</disp-formula>
where <italic>&#x03C7;</italic><sub><italic>i</italic></sub> &#x223C; Bernoulli(<italic>&#x03BB;</italic>/<italic>&#x03B1;</italic>), <inline-formula><alternatives><inline-graphic xlink:href="415208_inline22.gif"/></alternatives></inline-formula> and are independent. Thus
<disp-formula id="eqn27">
<alternatives><graphic xlink:href="415208_eqn27.gif"/></alternatives>
</disp-formula></p>
<p>Using a one-step conditioning argument on <italic>&#x03C7;</italic><sub>1</sub> and considering the Laplace transform for a unit rate exponential variable leads to the stated result.</p></statement>
<p>The first statement in Theorem (7) will be key to understanding the path distribution, discussed in <xref ref-type="sec" rid="s2c">Section 2.3</xref>, which justifies its prominence. It may be interpreted as indicating that if time is rescaled and we look at the distribution of <italic>T</italic> around <italic>&#x00B5;</italic>, an exponential distribution appears.</p>
<p>As discussed in <xref ref-type="sec" rid="s2b">Section 2.2</xref>, it is natural to consider the distribution of <italic>T</italic> conditioned that it is finite (we cannot discuss which path populated the target vertex if <italic>T</italic> = &#x221E;). However it is technically more convenient to condition on <italic>S</italic><sub>1</sub>, defined in (19). The following proposition states that in many relevant cases, namely large initial population, low death rate or small transition rates leaving vertex 1 these events are similar. Below, the superscript <italic>c</italic> denotes the complement of the set.</p>
<statement id="stat8">
<label>Proposition 1.</label>
<p><disp-formula id="ueqn36">
<alternatives><graphic xlink:href="415208_ueqn36.gif"/></alternatives>
</disp-formula>
<italic>where &#x03BD;</italic><sub>1</sub> = &#x03A3; <sub><italic>x</italic>&#x2208; <italic>&#x1D4A9;</italic> &#x002B;(1)</sub> <italic>&#x03BD;</italic>(1, <italic>x</italic>).</p>
<p><italic>Proof</italic>. As &#x2119; ({<italic>T</italic> &#x003C; &#x221E;}<sup><italic>c</italic></sup> &#x2229; <italic>S</italic><sub>1</sub>) = &#x2119; (<italic>T</italic> = &#x221E;&#x007C;<italic>S</italic><sub>1</sub>) &#x2119; (<italic>S</italic><sub>1</sub>) and &#x2119; (<italic>S</italic><sub>1</sub>) &#x003E; 0 we initially demonstrate
<disp-formula id="eqn28">
<alternatives><graphic xlink:href="415208_eqn28.gif"/></alternatives>
</disp-formula></p>
<p>Firstly recall that with <italic>W</italic> a s in Lemma 4, up to null events, {<italic>W</italic> &#x003E; 0} = <italic>S</italic><sub>1</sub>. Now <italic>T</italic> is the first arrival in a Cox process with intensity &#x03A3; <sub><italic>x</italic>&#x2208; <italic>&#x1D4A9;</italic>-(<italic>N</italic>)</sub> <italic>&#x03BD;</italic>(<italic>x, N</italic>) <italic>Z</italic><sub><italic>x</italic></sub>(<italic>s</italic>), and hence <italic>T</italic> &#x003C; &#x221E; with probability 1 on <italic>S</italic><sub>1</sub> if
<disp-formula id="eqn29">
<alternatives><graphic xlink:href="415208_eqn29.gif"/></alternatives>
</disp-formula>
with probability 1 on <italic>S</italic><sub>1</sub>. Observe that (29) is true as, by Theorem 6, for any realisation we may find <italic>t</italic><sub>1</sub> &#x2265; 0 such that
<disp-formula id="ueqn37">
<alternatives><graphic xlink:href="415208_ueqn37.gif"/></alternatives>
</disp-formula></p>
<p>As each <italic>&#x03D5;</italic><sub><italic>x</italic></sub> &#x003E; 0, due to each entry of <inline-formula><alternatives><inline-graphic xlink:href="415208_inline23a.gif"/></alternatives></inline-formula> also being positive [<xref ref-type="bibr" rid="c33">33</xref>], the right hand side of the above inequality is infinite a.s. on <italic>S</italic><sub>1</sub> which gives (28). It remains to bound <inline-formula><alternatives><inline-graphic xlink:href="415208_inline23.gif"/></alternatives></inline-formula>.</p>
<p>Let us introduce <italic>Z</italic><sup>&#x002A;</sup>(<italic>t</italic>) = &#x03A3;<sub><italic>i</italic>&#x2208; <italic>&#x1D4A9;</italic> &#x002B;(1)</sub> <italic>Z</italic><sup><italic>i</italic></sup>(<italic>t</italic>) and
<disp-formula id="ueqn38">
<alternatives><graphic xlink:href="415208_ueqn38.gif"/></alternatives>
</disp-formula></p>
<p>Note that we cannot hope to populate the target vertex without <italic>Z</italic><sup>&#x002A;</sup>(<italic>t</italic>) becoming positive. Therefore, {<italic>T</italic> &#x003C; &#x221E;} &#x2286; {<italic>&#x03C4;</italic> &#x003C; &#x221E;} which implies
<disp-formula id="ueqn39">
<alternatives><graphic xlink:href="415208_ueqn39.gif"/></alternatives>
</disp-formula></p>
<p>Hence our interest turns to the right hand side of the preceding inequality. The distribution of <italic>&#x03C4;</italic> is invariant to the growth at vertices <italic>i</italic> &#x2208; <italic>&#x1D4A9;</italic> <sup>&#x002B;</sup>(1), and so we let <italic>&#x03B1;</italic>(<italic>i</italic>) = <italic>&#x03B2;</italic>(<italic>i</italic>) = 0 for such <italic>i</italic>. The process (<italic>Z</italic><sub>1</sub>(<italic>t</italic>), <italic>Z</italic><sup>&#x002A;</sup>(<italic>t</italic>)) is a two-type branching process where cells of the second type (that contribute to <italic>Z</italic><sup>&#x002A;</sup>(<italic>t</italic>)) simply accumulate. For now assume <italic>z</italic> = 1. As
<disp-formula id="eqn30">
<alternatives><graphic xlink:href="415208_eqn30.gif"/></alternatives>
</disp-formula>
and from (20) we know <inline-formula><alternatives><inline-graphic xlink:href="415208_inline24a.gif"/></alternatives></inline-formula>, we now solve for the joint distribution of (<italic>Z</italic><sub>1</sub>(<italic>t</italic>), <italic>Z</italic><sup>&#x002A;</sup>(<italic>t</italic>)).</p>
<p>We introduce the generating functions
<disp-formula id="ueqn40">
<alternatives><graphic xlink:href="415208_ueqn40.gif"/></alternatives>
</disp-formula></p>
<p>Immediately <italic>G</italic><sup>&#x002A;</sup>(<italic>x, y, t</italic>) = <italic>y</italic> for all <italic>t</italic>. The backward Kolmogorov equation for <italic>G</italic><sub>1</sub> is
<disp-formula id="ueqn41">
<alternatives><graphic xlink:href="415208_ueqn41.gif"/></alternatives>
</disp-formula></p>
<p>By solving this equation (separation of variables with a partial fraction decomposition), and using the initial condition we find
<disp-formula id="ueqn42">
<alternatives><graphic xlink:href="415208_ueqn42.gif"/></alternatives>
</disp-formula></p>
<p>With
<disp-formula id="ueqn43">
<alternatives><graphic xlink:href="415208_ueqn43.gif"/></alternatives>
</disp-formula>
where <italic>q</italic><sub>1</sub> = <italic>&#x03B2;</italic><sub>1</sub>/<italic>&#x03B1;</italic> and <inline-formula><alternatives><inline-graphic xlink:href="415208_inline24.gif"/></alternatives></inline-formula>. Observe that <inline-formula><alternatives><inline-graphic xlink:href="415208_inline25.gif"/></alternatives></inline-formula> which implies <italic>r</italic><sub>2</sub> &#x2212; <italic>r</italic><sub>1</sub> &#x003C; 0. Hence
<disp-formula id="ueqn44">
<alternatives><graphic xlink:href="415208_ueqn44.gif"/></alternatives>
</disp-formula></p>
<p>We now have expressions for the final terms in (30) for <italic>z</italic> = 1. For <italic>z</italic> &#x2265; 1, we can use independence, and this leads to
<disp-formula id="ueqn45">
<alternatives><graphic xlink:href="415208_ueqn45.gif"/></alternatives>
</disp-formula></p>
<p>By examining the leading order with respect to the relevant variables we can conclude.</p></statement>
<p>We remark that if we instead wish to look at the case when the vertex <italic>N</italic> population arises and does not go extinct then &#x2119; (<italic>T</italic> = &#x221E;) = &#x2119; (All populations go extinct). The probability of population extinction is known to be given by an implicit equation involving the offspring distribution&#x2019;s generating function. This was the approach taken by [<xref ref-type="bibr" rid="c31">31</xref>]. The approximate solution for small transition rates was derived and agrees with the result presented above.</p>
<p>The above proposition yields &#x2119; (<italic>T</italic> &#x003C; &#x221E;) &#x2248; &#x2119; (<italic>S</italic><sub>1</sub>). Using this with (20) gives (5) in the main text. We now give consider the distribution of <italic>T</italic> given <italic>S</italic><sub>1</sub> (which we use as proxy for conditioning on a finite hitting time).</p>
<statement id="stat9">
<label>Corollary 7.1.</label>
<p>With the notation of Theorem 7,
<disp-formula id="ueqn46">
<alternatives><graphic xlink:href="415208_ueqn46.gif"/></alternatives>
</disp-formula></p>
<p><italic>Proof.</italic> Starting from the first statement in Theorem 7, we only need apply &#x1D53C; [&#x00B7; &#x007C; <italic>S</italic><sub>1</sub>]. The distribution of <italic>W&#x03BB;/&#x03B1;</italic> can be rewritten as
<disp-formula id="ueqn47">
<alternatives><graphic xlink:href="415208_ueqn47.gif"/></alternatives>
</disp-formula>
where <inline-formula><alternatives><inline-graphic xlink:href="415208_inline26.gif"/></alternatives></inline-formula> are rate one exponential variables, and <italic>K &#x223C;</italic> Binomial(<italic>z, &#x03BB;/&#x03B1;</italic>), independent of all <inline-formula><alternatives><inline-graphic xlink:href="415208_inline27.gif"/></alternatives></inline-formula>. Conditioning on <italic>S</italic><sub>1</sub> ensures that <italic>K &#x003E;</italic> 0.</p>
<p>Thus as in (27) we must calculate
<disp-formula id="ueqn48">
<alternatives><graphic xlink:href="415208_ueqn48.gif"/></alternatives>
</disp-formula></p>
<p>The binomial theorem leads to the stated expression.</p></statement>
<p>We now prove a corollary regarding <italic>&#x00B5;</italic>, which provides justification to (6).</p>
<statement id="stat10">
<label>Corollary 7.2.</label>
<p><italic>Let t</italic><sub>1<italic>/</italic>2</sub> <italic>be the median time for the vertex N population to arise, conditioned on S</italic><sub>1</sub>. <italic>That is t</italic><sub>1<italic>/</italic>2</sub> <italic>satisfies</italic>
<disp-formula id="eqn31">
<alternatives><graphic xlink:href="415208_eqn31.gif"/></alternatives>
</disp-formula></p>
<p><italic>Then</italic>
<disp-formula id="ueqn49">
<alternatives><graphic xlink:href="415208_ueqn49.gif"/></alternatives>
</disp-formula>
<italic>where</italic>
<disp-formula id="ueqn50">
<alternatives><graphic xlink:href="415208_ueqn50.gif"/></alternatives>
</disp-formula></p>
<p><italic>This also implies t</italic><sub>1<italic>/</italic>2</sub> <italic>&#x223C; &#x00B5; &#x2212; h</italic>(<italic>z</italic>). <italic>Regarding h</italic>(<italic>z</italic>) <italic>we have</italic>
<disp-formula id="ueqn51">
<alternatives><graphic xlink:href="415208_ueqn51.gif"/></alternatives>
</disp-formula></p>
<p><italic>Proof.</italic> We firstly note, as is apparent from the cumulative distribution function of <italic>T</italic> (see (23) for instance), that <italic>t</italic><sub>1<italic>/</italic>2</sub> is monotone increasing as <italic>v&#x002A;</italic> decreases. By (31)
<disp-formula id="ueqn52">
<alternatives><graphic xlink:href="415208_ueqn52.gif"/></alternatives>
</disp-formula></p>
<p>Taking the <italic>v&#x002A; &#x2192;</italic> 0 limit we find <italic>&#x03BB;</italic>(<italic>t</italic><sub>1<italic>/</italic>2</sub><italic>-&#x00B5;</italic>) <italic>&#x2192;x</italic>, where the convergence is guaranteed as both <italic>t</italic><sub>1<italic>/</italic>2</sub>, <italic>&#x00B5;</italic> are monotone increasing. Further, from Corollary 7.1, the limit <italic>x</italic> satisfies
<disp-formula id="ueqn53">
<alternatives><graphic xlink:href="415208_ueqn53.gif"/></alternatives>
</disp-formula></p>
<p>Solving for <italic>x</italic> leads to <italic>x</italic> = <italic>&#x2212;&#x03BB;h</italic>(<italic>z</italic>) as stated. For the asymptotic result we firstly consider
<disp-formula id="ueqn54">
<alternatives><graphic xlink:href="415208_ueqn54.gif"/></alternatives>
</disp-formula></p>
<p>Expansions on the numerator and denominator show that <italic>d</italic>(<italic>z</italic>) is <italic>O</italic>(<italic>z</italic><sup>&#x2212;2</sup>). Then
<disp-formula id="ueqn55">
<alternatives><graphic xlink:href="415208_ueqn55.gif"/></alternatives>
</disp-formula></p>
<p>As <inline-formula><alternatives><inline-graphic xlink:href="415208_inline28.gif"/></alternatives></inline-formula> we have shown the claimed asymptotic behaviour.</p></statement>
</sec>
<sec id="s5d">
<label>5.4</label>
<title>Path graph and acylic graphs</title>
<p>In this section we specialise the results of <xref ref-type="sec" rid="s5b">Sections 5.2</xref> and <xref ref-type="sec" rid="s5c">5.3</xref> firstly to the case of a path graph and then to acyclic graphs.</p>
<p>We first consider a path graph with <italic>N</italic> vertices and let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline29.gif"/></alternatives></inline-formula>. In this setting the matrix <italic>A</italic> from <xref ref-type="sec" rid="s5b">Section 5.2</xref> has entries
<disp-formula id="ueqn56">
<alternatives><graphic xlink:href="415208_ueqn56.gif"/></alternatives>
</disp-formula>
and the vector <italic>&#x03A8;</italic> has entries <italic>&#x03A8;</italic><sub><italic>i</italic></sub> = <italic>&#x03B1;</italic>(<italic>i</italic>)&#x002B; <italic>&#x03B2;</italic>(<italic>i</italic>) &#x002B; <italic>v</italic>(<italic>i, i</italic>&#x002B; 1) for <italic>i</italic> = 1, <italic>&#x2026;, N-</italic>1. We want a useful representation of the sequence <inline-formula><alternatives><inline-graphic xlink:href="415208_inline30.gif"/></alternatives></inline-formula>, which we recall is given in terms of the entries of the suitably normalised left and right eigenvectors of <italic>A</italic>. Because they are easier to work with (i.e. check they indeed are eigenvectors) we first introduce the unnormalised left and right vectors <italic>u&#x2032;, v&#x2032;</italic> with entries
<disp-formula id="ueqn57">
<alternatives><graphic xlink:href="415208_ueqn57.gif"/></alternatives>
</disp-formula></p>
<p>It may be directly verified that these are left and right eigenvectors for <italic>A</italic> with eigenvalue <italic>&#x03BB;</italic>. Now we normalise these, so that they agree with (22) via
<disp-formula id="ueqn58">
<alternatives><graphic xlink:href="415208_ueqn58.gif"/></alternatives>
</disp-formula></p>
<p>The following corollary demonstrates how the results of the previous section on population growth and time to reach the target simplifies in the path graph setting.</p>
<p><bold>Corollary 7.3.</bold> <italic>The results of <xref ref-type="sec" rid="s5b">Sections 5.2</xref> and <xref ref-type="sec" rid="s5c">5.3</xref> hold with the explicit representations</italic>
<disp-formula id="ueqn59">
<alternatives><graphic xlink:href="415208_ueqn59.gif"/></alternatives>
</disp-formula>
<italic>and</italic>
<disp-formula id="ueqn60">
<alternatives><graphic xlink:href="415208_ueqn60.gif"/></alternatives>
</disp-formula></p>
<p>We now move to the case where <italic>G</italic> is acyclic.</p>
<p>Recall the concept of vertex lineage from <xref ref-type="sec" rid="s2c">Section 2.3</xref>. We denote the number of cells at time <italic>t</italic> with vertex lineage <italic>p</italic> as <italic>X</italic>(<italic>p, t</italic>). The number of cells at a vertex is related to the cells with vertex lineages ending at that vertex via
<disp-formula id="eqn32">
<alternatives><graphic xlink:href="415208_eqn32.gif"/></alternatives>
</disp-formula></p>
<p>For any path <italic>p</italic>, as above we let the first <italic>j</italic> terms in <italic>p</italic> be denoted <italic>p</italic><sub>1:<italic>j</italic></sub>. The process <inline-formula><alternatives><inline-graphic xlink:href="415208_inline31.gif"/></alternatives></inline-formula> is a multitype branching process, and <italic>X</italic>(<italic>p</italic><sub>1:<italic>j</italic></sub>, <italic>t</italic>) represents the number of cells that have progressed to step <italic>j</italic> along path <italic>p</italic> at time <italic>t</italic>. Births occur to individuals of type <italic>i</italic> at at rate <italic>&#x03B1;</italic>(<italic>p</italic><sub><italic>i</italic></sub>), deaths at rate <italic>&#x03B2;</italic>(<italic>p</italic><sub><italic>i</italic></sub>) and individuals of type <italic>i</italic> transition to type <italic>i</italic> &#x002B; 1 at rate <italic>v</italic>(<italic>p</italic><sub><italic>i</italic></sub>, <italic>p</italic><sub><italic>i</italic>&#x002B;1</sub>). Thus we may use our results for path graphs with vertices labelled 1, <italic>&#x2026;, l</italic> &#x002B; 1. Hence via Theorem 6 and Corollary 7.3 we have the following.</p>
<p><bold>Corollary 7.4.</bold>
<disp-formula id="ueqn61">
<alternatives><graphic xlink:href="415208_ueqn61.gif"/></alternatives>
</disp-formula>
<italic>where w</italic>(<italic>p</italic>) <italic>is the path weight given in</italic> (2) <italic>and W is as in Lemma 4.</italic></p>
<p>Analogously to Corollary 7.3 we have the following statement regarding the growth of the population at the initial and intermediate vertices.</p>
<statement id="stat11">
<label>Corollary 7.5.</label>
<p><italic>The results of <xref ref-type="sec" rid="s5b">Sections 5.2</xref> and <xref ref-type="sec" rid="s5c">5.3</xref> hold with the explicit representations</italic>
<disp-formula id="ueqn62">
<alternatives><graphic xlink:href="415208_ueqn62.gif"/></alternatives>
</disp-formula>
<italic>where w</italic>(<italic>p</italic>) <italic>is the path weight given in</italic> (2).</p>
<p>Note that as the empty product is defined to be 1, <italic>&#x03D5;</italic> <sub>1</sub> = 1.</p>
<p><italic>Proof of Corollary 7.5.</italic> Due to Theorem 6 we must demonstrate
<disp-formula id="ueqn63">
<alternatives><graphic xlink:href="415208_ueqn63.gif"/></alternatives>
</disp-formula></p>
<p>By (32) it is enough to show
<disp-formula id="ueqn64">
<alternatives><graphic xlink:href="415208_ueqn64.gif"/></alternatives>
</disp-formula></p>
<p>Observe that for any events <inline-formula><alternatives><inline-graphic xlink:href="415208_inline32.gif"/></alternatives></inline-formula> such that for all <italic>i</italic>, &#x2119; (<italic>A</italic><sub><italic>i</italic></sub>) = 1 then <inline-formula><alternatives><inline-graphic xlink:href="415208_inline33.gif"/></alternatives></inline-formula>. Use this with events <inline-formula><alternatives><inline-graphic xlink:href="415208_inline34.gif"/></alternatives></inline-formula> to conclude.</p>
</statement>
<p>One particular consequence, by coupling Corollaries 7.1 and 7.5 is that for <italic>v&#x002A;</italic> small
<disp-formula id="eqn33">
<alternatives><graphic xlink:href="415208_eqn33.gif"/></alternatives>
</disp-formula>
which is the conditional version of (4).</p>
</sec>
<sec id="s5e">
<label>5.5</label>
<title>Theorem 2 Proof</title>
<p>We continue to take <italic>G</italic> acyclic. Note that &#x007C;<italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> &#x007C; is finite, and so we let <italic>n</italic> = &#x007C;<italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> &#x007C;. The elements of <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> can be enumerated and we use the following notation to do so <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> = {<italic>p</italic><sup>(1)</sup>, <italic>&#x2026;, p</italic><sup>(<italic>n</italic>)</sup>}. For each <italic>p</italic><sup>(<italic>i</italic>)</sup> &#x2208; <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> we let: the path lengths be <inline-formula><alternatives><inline-graphic xlink:href="415208_inline35a.gif"/></alternatives></inline-formula> be the final transition rates, and <italic>&#x03B7;</italic><sup>(<italic>i</italic>)</sup> = <italic>w</italic>(<italic>p</italic><sup>(<italic>i</italic>)</sup>)<italic>/u</italic><sup>(<italic>i</italic>)</sup>. Consider <italic>p</italic><sup>(<italic>i</italic>)</sup> &#x2208; <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> and recall that <inline-formula><alternatives><inline-graphic xlink:href="415208_inline35.gif"/></alternatives></inline-formula> represents the number of cells that have progressed to step <italic>j</italic> along path <italic>i</italic> at time <italic>t</italic>. If we apply the first statement in Theorem 7 to the branching process <inline-formula><alternatives><inline-graphic xlink:href="415208_inline36.gif"/></alternatives></inline-formula> we can deduce that under a time rescaling, the time to traverse path <italic>i</italic> is approximately exponentially distributed, conditional on the population growth along that path. Therefore the question of which path the target population arises from becomes equivalent to the minimum of a set of exponential random variables. To simplify notation we let,
<disp-formula id="ueqn65">
<alternatives><graphic xlink:href="415208_ueqn65.gif"/></alternatives>
</disp-formula>
where <italic>T</italic> (<italic>p</italic><sup>(<italic>i</italic>)</sup>) is defined in (9). Then we can prove the precise version of Theorem 2.</p>
<statement id="stat12">
<label>Theorem 8.</label>
<p><italic>Assume the limits</italic> <inline-formula><alternatives><inline-graphic xlink:href="415208_inline37.gif"/></alternatives></inline-formula> <italic>exist, but may be infinite, and further that there exists i&#x002A;</italic> &#x2208; {1, <italic>&#x2026;, n</italic>} <italic>such that <inline-formula><alternatives><inline-graphic xlink:href="415208_inline38.gif"/></alternatives></inline-formula> for all i</italic> = 1, <italic>&#x2026; n. Then, for p</italic> &#x2208; <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> <italic>and t</italic> &#x2208; &#x211D;,
<disp-formula id="ueqn66">
<alternatives><graphic xlink:href="415208_ueqn66.gif"/></alternatives>
</disp-formula></p>
<p><italic>Proof.</italic> Consider initially the case when <italic>n</italic> = 2, that is there are only two paths from vertex 1 to vertex <italic>N</italic>. These two paths must diverge before <italic>N</italic>. If the population growth along these paths until the target vertex is given, then <italic>T</italic> <sup>(1)</sup> and <italic>T</italic> <sup>(2)</sup> are the first arrival times in two independent non-homogeneous Poisson processes. Returning to arbitrary <italic>n</italic>, to use this fact we define the population numbers along all the paths up until the target vertex as
<disp-formula id="ueqn67">
<alternatives><graphic xlink:href="415208_ueqn67.gif"/></alternatives>
</disp-formula></p>
<p>So that we can use this conditional independence, and prior results, we note
<disp-formula id="eqn34">
<alternatives><graphic xlink:href="415208_eqn34.gif"/></alternatives>
</disp-formula></p>
<p>We now focus on the argument of the above expectation. Let the path under consideration be path 1 (<italic>p</italic> = <italic>p</italic><sup>(1)</sup>) and
<disp-formula id="ueqn68">
<alternatives><graphic xlink:href="415208_ueqn68.gif"/></alternatives>
</disp-formula></p>
<p>We know that each <italic>T</italic> <sup>(<italic>i</italic>)</sup> appropriately centred converges. If we centre each <italic>T</italic> <sup>(<italic>i</italic>)</sup> by the same quantity, then the ordering is preserved. That is, clearly <italic>T</italic> <sup>(1)</sup> <italic>&#x003C; T</italic> <sup>(2)</sup> &#x21D4;<italic>T</italic> <sup>(1)</sup> <italic>-&#x00B5;</italic><sup>(<italic>i</italic>)</sup> <italic>&#x003C; T</italic> <sup>(2)</sup> <italic>-&#x00B5;</italic><sup>(<italic>i</italic>)</sup> for any <italic>&#x00B5;</italic><sup>(<italic>i</italic>)</sup>. As <italic>T</italic> <sup>(<italic>i</italic>)</sup> is the target time along the path graph <italic>p</italic><sup>(<italic>i</italic>)</sup>, Corollary 7.3 gives the appropriate centring. In particular with
<disp-formula id="ueqn69">
<alternatives><graphic xlink:href="415208_ueqn69.gif"/></alternatives>
</disp-formula>
we have
<disp-formula id="ueqn70">
<alternatives><graphic xlink:href="415208_ueqn70.gif"/></alternatives>
</disp-formula></p>
<p>For order preservation (of the <italic>T</italic> <sup>(<italic>i</italic>)</sup>s) we take <inline-formula><alternatives><inline-graphic xlink:href="415208_inline38a.gif"/></alternatives></inline-formula> as a common centring of all <italic>T</italic> <sup>(<italic>i</italic>)</sup>, and use <inline-formula><alternatives><inline-graphic xlink:href="415208_inline38b.gif"/></alternatives></inline-formula> and
<disp-formula id="ueqn71">
<alternatives><graphic xlink:href="415208_ueqn71.gif"/></alternatives>
</disp-formula></p>
<p>Note the above expression may be <italic>-&#x221E;</italic> Using this, and exponentiating (which again preserves order), leads to
<disp-formula id="ueqn72">
<alternatives><graphic xlink:href="415208_ueqn72.gif"/></alternatives>
</disp-formula></p>
<p>At this point we note that if <italic>&#x03BA;</italic><sup>(<italic>i</italic>)</sup> = 0, then for fixed (&#x1D4B3; (<italic>s</italic>))<sub><italic>s&#x2265;</italic>0</sub>, the random variables <inline-formula><alternatives><inline-graphic xlink:href="415208_inline38c.gif"/></alternatives></inline-formula> converges to &#x002B;<italic>&#x221E;</italic> almost surely. Recall the <italic>T</italic> <sup>(<italic>i</italic>)</sup> are conditionally independent, and hence convergence of the marginal distributions implies joint convergence. Therefore for <inline-formula><alternatives><inline-graphic xlink:href="415208_inline38d.gif"/></alternatives></inline-formula> with each <italic>x</italic><sub><italic>j</italic></sub> <italic>&#x2265;</italic> 0, almost surely wehave
<disp-formula id="ueqn73">
<alternatives><graphic xlink:href="415208_ueqn73.gif"/></alternatives>
</disp-formula></p>
<p>Including the shift <italic>t</italic>, we have for fixed (&#x1D4B3; (<italic>s</italic>))<sub><italic>s&#x2265;</italic>0</sub> the random vector <inline-formula><alternatives><inline-graphic xlink:href="415208_inline39.gif"/></alternatives></inline-formula> jointly tends in distribution to the random vector <inline-formula><alternatives><inline-graphic xlink:href="415208_inline40.gif"/></alternatives></inline-formula>. If <italic>W</italic> = 0, all the <italic>U</italic><sub><italic>i</italic></sub> = &#x002B;<italic>&#x221E;</italic> a.s., instead if <italic>W &#x003E;</italic> 0 each <italic>U</italic><sub><italic>i</italic></sub> is independent and for 2 <italic>&#x2264; i &#x2264; n</italic> has distribution
<disp-formula id="ueqn74">
<alternatives><graphic xlink:href="415208_ueqn74.gif"/></alternatives>
</disp-formula>
where <italic>E</italic><sub><italic>i</italic></sub> is an exponential random variable with parameter <inline-formula><alternatives><inline-graphic xlink:href="415208_inline41.gif"/></alternatives></inline-formula>. For <italic>i</italic> = 1, instead we have <inline-formula><alternatives><inline-graphic xlink:href="415208_inline42.gif"/></alternatives></inline-formula> if <italic>&#x03BA;</italic><sup>(1)</sup> = 0, else <italic>U</italic><sub>1</sub> is distributed as an exponential with parameter <inline-formula><alternatives><inline-graphic xlink:href="415208_inline43.gif"/></alternatives></inline-formula> As, up to null events, {<italic>W &#x003E;</italic> 0} = <italic>S</italic><sub>1</sub>, and using standard results for the ordering of exponential variables (looking at the minimum of the <italic>U</italic><sub><italic>i</italic></sub>), we have
<disp-formula id="eqn35">
<alternatives><graphic xlink:href="415208_eqn35.gif"/></alternatives>
</disp-formula></p>
<p>The right hand side of (35) is an element of [0, <xref ref-type="bibr" rid="c1">1</xref>]. 0 is obtained when <italic>&#x03BA;</italic><sup>(1)</sup> = 0 (the final transition rate along the path is small relative to other paths) and 1 is obtained if <italic>&#x03BA;</italic><sup>(<italic>i</italic>)</sup> = <italic>&#x03B4;</italic><sub>1,<italic>i</italic></sub> (the final transition rate along the path is the largest relative to other paths). Coupling the above with (34) gives the result.</p></statement>
</sec>
<sec id="s5f">
<label>5.6</label>
<title>Cyclic graphs</title>
<p>Suppose <italic>G</italic> is as before, but without the acyclic assumption. For cyclic graphs in place of <italic>&#x1D4AB;</italic><sub>1,<italic>N</italic></sub> we must consider <italic>&#x1D4B2;</italic><sub>1,<italic>N</italic></sub>, which we define to be the set of walks between the root and vertex <italic>N</italic>. The definition of vertex lineages holds identically for walks. Therefore for <italic>&#x03C9;</italic> &#x2208; <italic>&#x1D4B2;</italic><sub>1,<italic>N</italic></sub> we let
<disp-formula id="eqn36">
<alternatives><graphic xlink:href="415208_eqn36.gif"/></alternatives>
</disp-formula>
where <italic>X</italic> (<italic>&#x03C9;, t</italic>) is as given in <xref ref-type="sec" rid="s2c">Section 2.3</xref>. Here we show that so long as the number of transitions between vertices is finite, which corresponds to finitely many back transitions, we may map a graph containing cycles to an acyclic one and then use the results given above.</p>
<p>The set of walks between the root and the target vertex of length at most <italic>i</italic> &#x2212; 1 will be denoted
<disp-formula id="ueqn75">
<alternatives><graphic xlink:href="415208_ueqn75.gif"/></alternatives>
</disp-formula></p>
<p>Further for a graph <italic>G</italic> = (<italic>V, E</italic>), let the vertex parameters be the birth and death rates associated to the vertices of <italic>G</italic> and the edge parameters the transition rates associated with the edges.</p>
<statement id="stat13">
<label>Proposition 2.</label>
<p><italic>For a given graph G</italic> = (<italic>V, E</italic>) <italic>with associated vertex and edge parameters and fixed upper-length i &#x2265;</italic> 1, <italic>we can construct an acyclic graph G&#x2032;</italic> = (<italic>V &#x2032;, E&#x2032;</italic>) <italic>(dependent on i), which coupled with appropriate vertex and edge parameters, permits a bijection <inline-formula><alternatives><inline-graphic xlink:href="415208_inline44.gif"/></alternatives></inline-formula>. This bijection possesses the property that for <inline-formula><alternatives><inline-graphic xlink:href="415208_inline44a.gif"/></alternatives></inline-formula></italic>
<disp-formula id="ueqn76">
<alternatives><graphic xlink:href="415208_ueqn76.gif"/></alternatives>
</disp-formula>
<italic>where T &#x2032;</italic>(<italic>g</italic>(<italic>&#x03C9;</italic>)) <italic>is defined as in</italic> (36) <italic>but with the process on G&#x2032; with its associated parameters.</italic></p>
<p>Before giving the proof we briefly demonstrate this on the graphs shown in <xref rid="fig8" ref-type="fig">Fig. 8</xref>. This elucidates the general idea.</p>
<p>Here
<disp-formula id="ueqn77">
<alternatives><graphic xlink:href="415208_ueqn77.gif"/></alternatives>
</disp-formula></p>
<p>It is clear these may be mapped to the paths in <italic>G&#x2032;</italic>
<disp-formula id="ueqn78">
<alternatives><graphic xlink:href="415208_ueqn78.gif"/></alternatives>
</disp-formula></p>
<p>Further <inline-formula><alternatives><inline-graphic xlink:href="415208_inline45.gif"/></alternatives></inline-formula> so long as the transition rates associated with edges (1, 2) and (2, 4) on <italic>G</italic> are equal to the rates with (1, 2) and (2, 6) on <italic>G&#x2032;</italic> and that the birth and death rates at vertices 1 and 2 are equal in both cases.</p>
<p><italic>Proof of Proposition 2.</italic> To avoid cumbersome notation and as the idea is illustrated in <xref rid="fig8" ref-type="fig">Fig. 8</xref> we sketch an algorithm. We enumerate the set <inline-formula><alternatives><inline-graphic xlink:href="415208_inline46.gif"/></alternatives></inline-formula>, where <inline-formula><alternatives><inline-graphic xlink:href="415208_inline47.gif"/></alternatives></inline-formula>. Again we use the notation <italic>l</italic><sup>(<italic>j</italic>)</sup> for the length of the <italic>j</italic>th walk, that is <italic>l</italic><sup>(<italic>j</italic>)</sup> = &#x007C;<italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup>&#x007C; <italic>-</italic> 1. The graph <italic>G&#x2032;</italic> is constructed iteratively. Let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline48.gif"/></alternatives></inline-formula>, where <italic>N &#x2032;</italic> is a placeholder and will ultimately be &#x007C;<italic>V &#x2032;</italic>&#x007C;. Similarly <inline-formula><alternatives><inline-graphic xlink:href="415208_inline49.gif"/></alternatives></inline-formula> and <italic>p</italic><sup>(1)</sup> = (1, 2, <italic>&#x2026;, l</italic><sup>(1)</sup>, <italic>N &#x2032;</italic>).</p>
<p>Then for each further <italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup>, 2 <italic>&#x2264; j &#x2264; &#x2133;</italic>, from the previously considered walks select the walk that <italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup> &#x2018;agrees with the longest&#x2019;, say <italic>&#x03C9;</italic><sup>(<italic>k</italic>)</sup>, 1 <italic>&#x2264; k &#x003C; j</italic>. If <italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup> and <italic>&#x03C9;</italic><sup>(<italic>k</italic>)</sup> agree up until their <italic>m</italic>th element, and <italic>l</italic><sup>(<italic>j</italic>)</sup> <italic>&#x2212; m &#x003E;</italic> 0 then add <italic>l</italic><sup>(<italic>j</italic>)</sup> <italic>&#x2212; m</italic> elements to <inline-formula><alternatives><inline-graphic xlink:href="415208_inline50a.gif"/></alternatives></inline-formula> (new vertices starting with <inline-formula><alternatives><inline-graphic xlink:href="415208_inline50.gif"/></alternatives></inline-formula>. This creates <inline-formula><alternatives><inline-graphic xlink:href="415208_inline51.gif"/></alternatives></inline-formula>. Denote the new vertices as <inline-formula><alternatives><inline-graphic xlink:href="415208_inline52.gif"/></alternatives></inline-formula>. To <italic>E</italic><sub><italic>j</italic>&#x2013;1</sub> add the edges <inline-formula><alternatives><inline-graphic xlink:href="415208_inline53.gif"/></alternatives></inline-formula>, <inline-formula><alternatives><inline-graphic xlink:href="415208_inline54.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="415208_inline55.gif"/></alternatives></inline-formula>. This creates <italic>E</italic><sub><italic>j</italic></sub>. For <italic>p</italic><sup>(<italic>j</italic>)</sup> we let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline56.gif"/></alternatives></inline-formula> and then add the new vertices of <inline-formula><alternatives><inline-graphic xlink:href="415208_inline57.gif"/></alternatives></inline-formula>, and terminate the path at <italic>N &#x2032;</italic>. If <italic>l</italic><sup>(<italic>j</italic>)</sup> = <italic>m</italic> (and so the walk <italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup> agrees with <italic>&#x03C9;</italic><sup>(<italic>k</italic>)</sup> until its final element) let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline58.gif"/></alternatives></inline-formula> and add the edge <inline-formula><alternatives><inline-graphic xlink:href="415208_inline59.gif"/></alternatives></inline-formula> to <inline-formula><alternatives><inline-graphic xlink:href="415208_inline60.gif"/></alternatives></inline-formula>. Then <italic>p</italic><sup>(<italic>j</italic>)</sup> is equal to <inline-formula><alternatives><inline-graphic xlink:href="415208_inline61.gif"/></alternatives></inline-formula> concatenated with <italic>N&#x2032;</italic>. Finally our constructed graph is <inline-formula><alternatives><inline-graphic xlink:href="415208_inline62.gif"/></alternatives></inline-formula> with <italic>N&#x2032;</italic> = &#x007C;<italic>V &#x2032;</italic>&#x007C;.</p>
<p>Identifying <italic>g</italic>(<italic>&#x03C9;</italic><sup><italic>(i)</italic></sup>) = <italic>p</italic><sup><italic>(i)</italic></sup>, we see that if <italic>&#x03C9;</italic><sup><italic>(i)</italic></sup>, <italic>&#x03C9;</italic>(<italic>k</italic>) agree until their <italic>m</italic>th element then so also will <italic>g</italic>(<italic>&#x03C9;</italic><sup>(<italic>j</italic>)</sup>), <italic>g</italic>(<italic>&#x03C9;</italic><sup>(<italic>k</italic>)</sup>), but after this the paths diverge. We further require that the birth and death rates for the population type represented by the <italic>k</italic>th element of <italic>&#x03C9;</italic> should be the same as the <italic>k</italic>th element of <italic>g</italic>(<italic>&#x03C9;</italic>). Similarly for the transition rates between the <italic>k</italic>th and <italic>k</italic> &#x002B; 1th element of <italic>&#x03C9;</italic> and <italic>g</italic>(<italic>&#x03C9;</italic>).</p></statement>
<fig id="fig8" position="float" fig-type="figure">
<label>Figure 8:</label>
<caption><p>Mapping cyclic graphs to acyclic graphs</p></caption>
<graphic xlink:href="415208_fig8.tif"/>
</fig>
<p>Coupling the above proposition with the results of <xref ref-type="sec" rid="s5d">Section 5.4</xref> allows one to characterise
<disp-formula id="ueqn79">
<alternatives><graphic xlink:href="415208_ueqn79.gif"/></alternatives>
</disp-formula>
in terms of the weights of the walks. Further for a set of walks <inline-formula><alternatives><inline-graphic xlink:href="415208_inline63.gif"/></alternatives></inline-formula>, Theorem 2 holds but now with the walk weights, defined analogously to the definition given in (2).</p>
<p>However, the following result demonstrates that when the transition rates between vertices are small, the first initiation of the target is dominated by the paths, as opposed to walks containing cycles, which offers a secondary justification for mainly focusing on acyclic graphs. To state the result let us define <italic>q</italic>: <italic>&#x1D4B2;</italic> <sub>1,<italic>N</italic></sub> <italic>&#x2192; &#x1D4AB;</italic> <sub>1,<italic>N</italic></sub> as the operation reducing walks to their respective paths. This may be accomplished recursively by searching for the first cycle in <italic>&#x03C9;</italic> and replacing this with the first element in the cycle. Then repeating the same procedure on the reduced walk until it is a path. This operation is the same as that which maps trajectories to their corresponding trajectory class in [<xref ref-type="bibr" rid="c46">46</xref>]. Further, for <italic>p</italic> &#x2208; <italic>&#x1D4AB;</italic> <sub>1,<italic>N</italic></sub> let
<disp-formula id="ueqn80">
<alternatives><graphic xlink:href="415208_ueqn80.gif"/></alternatives>
</disp-formula>
that is the walks of length at most <italic>i-</italic>1 which when reduced to paths are <italic>p</italic>, but excluding <italic>p</italic> itself. Then with
<disp-formula id="ueqn81">
<alternatives><graphic xlink:href="415208_ueqn81.gif"/></alternatives>
</disp-formula>
we have the following.</p>
<statement id="stat14">
<label>Proposition 3.</label>
<p><italic>For i &#x2265;</italic> 1, <italic>p</italic> &#x2208; <italic>&#x1D4AB;</italic> <sub>1,<italic>N</italic></sub> <italic>such that &#x1D4B2;</italic> <sup>(<italic>i</italic>)</sup>[<italic>p</italic>] <italic>is non-empty, and all &#x03C9;</italic> &#x2208; <italic>&#x1D4B2;</italic> <sup>(<italic>i</italic>)</sup>[<italic>p</italic>]
<disp-formula id="ueqn82">
<alternatives><graphic xlink:href="415208_ueqn82.gif"/></alternatives>
</disp-formula></p>
<p><italic>Proof.</italic> We construct an acyclic graph with appropriate vertex and edge parameters as in Proposition 2 and use the mapping <italic>g</italic> from there with domain <inline-formula><alternatives><inline-graphic xlink:href="415208_inline64.gif"/></alternatives></inline-formula>. As before let <inline-formula><alternatives><inline-graphic xlink:href="415208_inline65.gif"/></alternatives></inline-formula> be the codomain of <italic>g</italic>. Then for path <inline-formula><alternatives><inline-graphic xlink:href="415208_inline66.gif"/></alternatives></inline-formula> and walk <inline-formula><alternatives><inline-graphic xlink:href="415208_inline67.gif"/></alternatives></inline-formula>. Note due to the manner in which the edge parameters are chosen {<italic>v</italic>(<italic>i, N</italic>): <italic>i</italic> &#x2208; <italic>&#x1D4A9;</italic> <sup>&#x2212;</sup>(<italic>N</italic>)} = {<italic>v</italic>(<italic>i,</italic> &#x007C;<italic>V &#x2032;</italic>&#x007C;): <italic>i</italic> &#x2208; <italic>&#x1D4A9;</italic> <sup>&#x2212;</sup>(&#x007C;<italic>V &#x2032;</italic>&#x007C;)} and hence <italic>v&#x002A;</italic> remains unchanged. Similarly <italic>v</italic><sub>max</sub> is unchanged. Therefore,
<disp-formula id="ueqn83">
<alternatives><graphic xlink:href="415208_ueqn83.gif"/></alternatives>
</disp-formula></p>
<p>Furthermore each vertex and edge in <italic>p</italic> is also present in <italic>&#x03C9;</italic>. Hence the weight of <italic>g</italic>(<italic>&#x03C9;</italic>) satisfies <inline-formula><alternatives><inline-graphic xlink:href="415208_inline68.gif"/></alternatives></inline-formula> where <inline-formula><alternatives><inline-graphic xlink:href="415208_inline69.gif"/></alternatives></inline-formula> is the product of transition rates along the edges existing in cycles in <italic>&#x03C9;</italic> divided by the costs of vertices in the cycles. Then by Theorem 2
<disp-formula id="ueqn84">
<alternatives><graphic xlink:href="415208_ueqn84.gif"/></alternatives>
</disp-formula></p>
<p>As <inline-formula><alternatives><inline-graphic xlink:href="415208_inline70.gif"/></alternatives></inline-formula> contains transition rates, this leads to the stated result upon taking <italic>v</italic><sub>max</sub> <italic>&#x2192;</italic> 0.</p></statement>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="c1"><label>[1]</label><mixed-citation publication-type="journal"><string-name><given-names>D. I.</given-names> <surname>Andersson</surname></string-name> and <string-name><given-names>D.</given-names> <surname>Hughes</surname></string-name>, <article-title>Antibiotic resistance and its cost: is it possible to reverse resistance?</article-title>, <source>Nature Reviews Microbiology</source>, (<year>2010</year>).</mixed-citation></ref>
<ref id="c2"><label>[2]</label><mixed-citation publication-type="book"><string-name><given-names>K. B.</given-names> <surname>Athreya</surname></string-name> and <string-name><given-names>P. E.</given-names> <surname>Ney</surname></string-name>, <source>Branching Processes</source>, <publisher-name>Dover Publications</publisher-name>, <year>2004</year>.</mixed-citation></ref>
<ref id="c3"><label>[3]</label><mixed-citation publication-type="journal"><string-name><given-names>N.</given-names> <surname>Beerenwinkel</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Antal</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Dingli</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Traulsen</surname></string-name>, <string-name><given-names>K. W.</given-names> <surname>Kinzler</surname></string-name>, <string-name><given-names>V. E.</given-names> <surname>Velculescu</surname></string-name>,<string-name><given-names>B.</given-names> <surname>Vogelstein</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <article-title>Genetic progression and the waiting time to cancer</article-title>, <source>PLOS Computational Biology</source>, <volume>3</volume> (<year>2007</year>), pp. <fpage>1</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c4"><label>[4]</label><mixed-citation publication-type="journal"><string-name><given-names>J.</given-names> <surname>Berestycki</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Brunet</surname></string-name>, and <string-name><given-names>Z.</given-names> <surname>Shi</surname></string-name>, <article-title>The number of accessible paths in the hypercube</article-title>, <source>Bernoulli</source>, <volume>22</volume> (<year>2016</year>), pp. <fpage>653</fpage>&#x2013;<lpage>680</lpage>.</mixed-citation></ref>
<ref id="c5"><label>[5]</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Bixby</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Talpaz</surname></string-name>, <article-title>Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia</article-title>, <source>Leukemia</source>, <volume>25</volume> (<year>2010</year>), p. <fpage>7</fpage>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label><mixed-citation publication-type="journal"><string-name><given-names>I.</given-names> <surname>Bozic</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Gerold</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <article-title>Quantifying clonal and subclonal passenger mutations in cancer evolution</article-title>, <source>PLOS Computational Biology</source>, <volume>12</volume> (<year>2016</year>), pp. <fpage>1</fpage>&#x2013;<lpage>19</lpage>.</mixed-citation></ref>
<ref id="c7"><label>[7]</label><mixed-citation publication-type="journal"><string-name><given-names>I.</given-names> <surname>Bozic</surname></string-name>, <string-name><given-names>J. G.</given-names> <surname>Reiter</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Allen</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Antal</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Chatterjee</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Shah</surname></string-name>, <string-name><given-names>Y. S.</given-names> <surname>Moon</surname></string-name>, <string-name><given-names>A. Yaqu-</given-names> <surname>bie</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Kelly</surname></string-name>, <string-name><given-names>D. T.</given-names> <surname>Le</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Lipson</surname></string-name>, <string-name><given-names>P. B.</given-names> <surname>Chapman</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Diaz</surname></string-name>, <string-name><surname>Luis</surname> <given-names>A</given-names></string-name>, <string-name><given-names>B.</given-names> <surname>Vogelstein</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <article-title>Evolutionary dynamics of cancer in response to targeted combination therapy</article-title>, <source>eLife</source>, <volume>2</volume> (<year>2013</year>), p. <fpage>e00747</fpage>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label><mixed-citation publication-type="other"><string-name><given-names>D.</given-names> <surname>Cheek</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Antal</surname></string-name>, <article-title>Mutation frequencies in a birth-death branching process</article-title>, <source>ArXiv e-prints</source>, (<year>2017</year>).</mixed-citation></ref>
<ref id="c9"><label>[9]</label><mixed-citation publication-type="journal"><string-name><given-names>T.</given-names> <surname>Cihlar</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Fordyce</surname></string-name>, <article-title>Current status and prospects of hiv treatment</article-title>, <source>Current Opinion in Virology</source>, <volume>18</volume> (<year>2016</year>), pp. <fpage>50</fpage>&#x2013;<lpage>56</lpage>. Antiviral strategies <italic>&#x2022;</italic> Virus structure and expression.</mixed-citation></ref>
<ref id="c10"><label>[10]</label><mixed-citation publication-type="journal"><string-name><given-names>C.</given-names> <surname>Colijn</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Cohen</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Ganesh</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Murray</surname></string-name>, <article-title>Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy</article-title>, <source>PLoS One</source>, <volume>6</volume> (<year>2011</year>), pp. <fpage>1</fpage>&#x2013;<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label><mixed-citation publication-type="book"><string-name><given-names>T. H.</given-names> <surname>Cormen</surname></string-name>, <string-name><given-names>C. E.</given-names> <surname>Leiserson</surname></string-name>, <string-name><given-names>R. L.</given-names> <surname>Rivest</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Stein</surname></string-name>, <chapter-title>Introduction to Algorithms, Third Edition</chapter-title>, vol. <volume>7</volume>, <publisher-name>The MIT Press, Cambridge, Massachusetts</publisher-name>., <edition>third ed.</edition>, <year>2009</year>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label><mixed-citation publication-type="journal"><string-name><given-names>J. A. G. M.</given-names> <surname>de Visser</surname></string-name> and <string-name><given-names>J.</given-names> <surname>Krug</surname></string-name>, <article-title>Empirical fitness landscapes and the predictability of evolution</article-title>, <source>Nature Reviews Genetics</source>, <volume>15</volume> (<year>2014</year>), p. <fpage>480</fpage>.</mixed-citation></ref>
<ref id="c13"><label>[13]</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Deresinski</surname></string-name>, <article-title>Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections</article-title>, <source>Clinical Infectious Diseases</source>, <volume>49</volume> (<year>2009</year>), pp. <fpage>1072</fpage>&#x2013;<lpage>1079</lpage>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label><mixed-citation publication-type="journal"><string-name><given-names>A.</given-names> <surname>Dewanji</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Jeon</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Mexa</surname></string-name>, and <string-name><given-names>E. G.</given-names> <surname>Luebeck</surname></string-name>, <article-title>Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer</article-title>, <source>PLoS Computational Biology</source>, <volume>7</volume> (<year>2011</year>).</mixed-citation></ref>
<ref id="c15"><label>[15]</label><mixed-citation publication-type="book"><string-name><given-names>R.</given-names> <surname>Durrett</surname></string-name>, <chapter-title>Branching Process Models of Cancer</chapter-title>, <source>Stochastics in Biological Systems</source>, <publisher-name>Springer</publisher-name>, <year>2015</year>.</mixed-citation></ref>
<ref id="c16"><label>[16]</label><mixed-citation publication-type="journal"><string-name><given-names>R.</given-names> <surname>Durrett</surname></string-name> and <string-name><given-names>S.</given-names> <surname>Moseley</surname></string-name>, <article-title>Evolution of resistance and progression to disease during clonal expansion of cancer</article-title>, <source>Theoretical Population Biology</source>, <volume>77</volume> (<year>2010</year>), pp. <fpage>42</fpage>&#x2013;<lpage>48</lpage>.</mixed-citation></ref>
<ref id="c17"><label>[17]</label><mixed-citation publication-type="journal"><string-name><given-names>R.</given-names> <surname>Durrett</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Schmidt</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Scweinsberg</surname></string-name>, <article-title>A waiting time problem arising from the study of mutli-stage carcinogenesis</article-title>, <source>The Annals of Applied Probability</source>, <volume>19</volume> (<year>2009</year>), pp. <fpage>676</fpage>&#x2013;<lpage>718</lpage>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label><mixed-citation publication-type="journal"><string-name><given-names>P. M.</given-names> <surname>Enriquez-Navas</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kam</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Das</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hassan</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Silva</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Foroutan</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Ruiz</surname></string-name>, <string-name><given-names>G. Mar-</given-names> <surname>tinez</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Minton</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Gillies</surname></string-name>, and <string-name><given-names>R. A.</given-names> <surname>Gatenby</surname></string-name>, <article-title>Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer</article-title>, <source>Science Translational Medicine</source>, <volume>8</volume> (<year>2016</year>), pp. <fpage>327ra24</fpage>&#x2013;<lpage>327ra24</lpage>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label><mixed-citation publication-type="journal"><string-name><given-names>C. B.</given-names> <surname>Ford</surname></string-name>, <string-name><given-names>R. R.</given-names> <surname>Shah</surname></string-name>, <string-name><given-names>M. K.</given-names> <surname>Maeda</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Gagneux</surname></string-name>, <string-name><given-names>M. B.</given-names> <surname>Murray</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Cohen</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Johnston</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Gardy</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lipsitch</surname></string-name>, and <string-name><given-names>S. M.</given-names> <surname>Fortune</surname></string-name>, <article-title>Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis</article-title>, <source>Nature Genetics</source>, <volume>45</volume> (<year>2013</year>), pp. <fpage>784</fpage>&#x2013;<lpage>790</lpage>.</mixed-citation></ref>
<ref id="c20"><label>[20]</label><mixed-citation publication-type="journal"><string-name><given-names>F.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Bonhoeffer</surname></string-name>, <article-title>Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy</article-title>, <source>PLoS Computational Biology</source>, <volume>11</volume> (<year>2015</year>).</mixed-citation></ref>
<ref id="c21"><label>[21]</label><mixed-citation publication-type="journal"><string-name><given-names>R.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>T. O.</given-names> <surname>McDonald</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Sei</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>P.-C.</given-names> <surname>Tsai</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Casasent</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Waters</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Meric-Bernstam</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, and <string-name><given-names>N. E.</given-names> <surname>Navin</surname></string-name>, <article-title>Punctuated copy number evolution and clonal stasis in triple-negative breast cancer</article-title>, <source>Nature Genetics</source>, <volume>48</volume> (<year>2016</year>), p. <fpage>1119</fpage>.</mixed-citation></ref>
<ref id="c22"><label>[22]</label><mixed-citation publication-type="journal"><string-name><given-names>J. H.</given-names> <surname>Gillespie</surname></string-name>, <article-title>A simple stochastic gene substitution model</article-title>, <source>Theoretical Population Biology</source>, <volume>23</volume> (<year>1983</year>), pp. <fpage>202</fpage>&#x2013;<lpage>215</lpage>.</mixed-citation></ref>
<ref id="c23"><label>[23]</label><mixed-citation publication-type="journal"><string-name><given-names>C. S.</given-names> <surname>Gokhale</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Iwasa</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Traulsen</surname></string-name>, <article-title>The pace of evolution across fitness valleys</article-title>, <source>Journal of Theoretical Biology</source>, <volume>259</volume> (<year>2009</year>), pp. <fpage>613</fpage>&#x2013;<lpage>620</lpage>.</mixed-citation></ref>
<ref id="c24"><label>[24]</label><mixed-citation publication-type="journal"><string-name><given-names>P.</given-names> <surname>Greulich</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Waclaw</surname></string-name>, and <string-name><given-names>R. J.</given-names> <surname>Allen</surname></string-name>, <article-title>Mutational pathway determines whether drug gradients accelerate evolution of drug-resistant cells</article-title>, <source>Phys. Rev. Lett</source>., <volume>109</volume> (<year>2012</year>), p. <fpage>088101</fpage>.</mixed-citation></ref>
<ref id="c25"><label>[25]</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Haeno</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Gonen</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Herman</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Iacobuzio-Donahue</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, <article-title>Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies</article-title>, <source>Cell</source>, <volume>148</volume> (<year>2012</year>), pp. <fpage>362</fpage>&#x2013;<lpage>375</lpage>.</mixed-citation></ref>
<ref id="c26"><label>[26]</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Haeno</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Iwasa</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, <article-title>The evolution of two mutations during clonal expansion</article-title>, <source>Genetics</source>, <volume>177</volume> (<year>2007</year>), pp. <fpage>2209</fpage>&#x2013;<lpage>2221</lpage>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label><mixed-citation publication-type="journal"><string-name><given-names>A. R.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Iles</surname></string-name>, and <string-name><given-names>R. C.</given-names> <surname>MacLean</surname></string-name>, <article-title>The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase</article-title>, <source>Genetics</source>, <volume>187</volume> (<year>2011</year>), pp. <fpage>817</fpage>&#x2013;<lpage>822</lpage>.</mixed-citation></ref>
<ref id="c28"><label>[28]</label><mixed-citation publication-type="journal"><string-name><given-names>R.</given-names> <surname>Hermsen</surname></string-name>, <string-name><given-names>J. B.</given-names> <surname>Deris</surname></string-name>, and <string-name><given-names>T.</given-names> <surname>Hwa</surname></string-name>, <article-title>On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient</article-title>, <source>Proceedings of the National Academy of Sciences</source>, <volume>109</volume> (<year>2012</year>), pp. <fpage>10775</fpage>&#x2013;<lpage>10780</lpage>.</mixed-citation></ref>
<ref id="c29"><label>[29]</label><mixed-citation publication-type="journal"><string-name><given-names>R.</given-names> <surname>Hermsen</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Hwa</surname></string-name>, <article-title>Sources and sinks: A stochastic model of evolution in heterogeneous environments</article-title>, <source>Phys. Rev. Lett</source>., <volume>105</volume> (<year>2010</year>), p. <fpage>248104</fpage>.</mixed-citation></ref>
<ref id="c30"><label>[30]</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Hughes</surname></string-name> and <string-name><given-names>D. I.</given-names> <surname>Andersson</surname></string-name>, <article-title>Evolutionary consequences of drug resistance: Shared principles across diverse targets and organisms</article-title>, <source>Nature Reviews Genetics</source>, <volume>16</volume> (<year>2015</year>), pp. <fpage>459</fpage>&#x2013;<lpage>471</lpage>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label><mixed-citation publication-type="journal"><string-name><given-names>Y.</given-names> <surname>Iwasa</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <article-title>Evolutionary dynamics of invasion and escape</article-title>, <source>Journal of Theoretical Biology</source>, <volume>226</volume> (<year>2004</year>), pp. <fpage>205</fpage>&#x2013;<lpage>214</lpage>.</mixed-citation></ref>
<ref id="c32"><label>[32]</label><mixed-citation publication-type="journal"><string-name><given-names>Y.</given-names> <surname>Iwasa</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, <article-title>Evolution of resistance during clonal expansion</article-title>, <source>Genetics</source>, <volume>172</volume> (<year>2006</year>), pp. <fpage>2557</fpage>&#x2013;<lpage>2566</lpage>.</mixed-citation></ref>
<ref id="c33"><label>[33]</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Janson</surname></string-name>, <article-title>Functional limit theorems for multitype branching processes and generalized P&#x00F3;lya urns</article-title>, <source>Stochastic Processes and their Applications</source>, <volume>110</volume> (<year>2004</year>), pp. <fpage>177</fpage>&#x2013;<lpage>245</lpage>.</mixed-citation></ref>
<ref id="c34"><label>[34]</label><mixed-citation publication-type="journal"><string-name><given-names>D. A.</given-names> <surname>Kessler</surname></string-name>, <string-name><given-names>R. H.</given-names> <surname>Austin</surname></string-name>, and <string-name><given-names>H.</given-names> <surname>Levine</surname></string-name>, <article-title>Resistance to chemotherapy: patient variability and cellular heterogeneity</article-title>., <source>Cancer research</source>, <volume>74</volume> (<year>2014</year>), pp. <fpage>4663</fpage>&#x2013;<lpage>70</lpage>.</mixed-citation></ref>
<ref id="c35"><label>[35]</label><mixed-citation publication-type="journal"><string-name><given-names>N. L.</given-names> <surname>Komarova</surname></string-name> and <string-name><given-names>D.</given-names> <surname>Wodarz</surname></string-name>, <article-title>Drug resistance in cancer: Principles of emergence and prevention</article-title>, <source>Proceedings of the National Academy of Sciences</source>, <volume>102</volume> (<year>2005</year>), pp. <fpage>9714</fpage>&#x2013;<lpage>9719</lpage>.</mixed-citation></ref>
<ref id="c36"><label>[36]</label><mixed-citation publication-type="journal"><string-name><given-names>K.</given-names> <surname>Leder</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Foo</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Skaggs</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Gorre</surname></string-name>, <string-name><given-names>C. L.</given-names> <surname>Sawyers</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, <article-title>Fitness conferred by bcr-abl kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia</article-title>, <source>PLoS One</source>, <volume>6</volume> (<year>2011</year>), pp. <fpage>1</fpage>&#x2013;<lpage>11</lpage>.</mixed-citation></ref>
<ref id="c37"><label>[37]</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Popodi</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Tang</surname></string-name>, and <string-name><given-names>P. L.</given-names> <surname>Foster</surname></string-name>, <article-title>Rate and molecular spectrum of spontaneous mutations in the bacterium escherichia coli as determined by whole-genome sequencing</article-title>, <source>Proceedings of the National Academy of Sciences</source>, <volume>109</volume> (<year>2012</year>), pp. <fpage>E2774</fpage>&#x2013;<lpage>E2783</lpage>.</mixed-citation></ref>
<ref id="c38"><label>[38]</label><mixed-citation publication-type="journal"><string-name><given-names>S. E.</given-names> <surname>Luria</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Delbr&#x00FC;ck</surname></string-name>, <article-title>Mutations of bacteria from virus sensitivity to virus resistance</article-title>, <source>Genetics</source>, <volume>48</volume> (<year>1943</year>), pp. <fpage>491</fpage>&#x2013;<lpage>511</lpage>.</mixed-citation></ref>
<ref id="c39"><label>[39]</label><mixed-citation publication-type="journal"><string-name><given-names>F.</given-names> <surname>Michor</surname></string-name>, <string-name><given-names>T. P.</given-names> <surname>Hughes</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Iwasa</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Branford</surname></string-name>, <string-name><given-names>N. P.</given-names> <surname>Shah</surname></string-name>, <string-name><given-names>C. L.</given-names> <surname>Sawyers</surname></string-name>, and <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <article-title>Dynamics of chronic myeloid leukaemia</article-title>., <source>Nature</source>, <volume>435</volume> (<year>2005</year>), pp. <fpage>1267</fpage>&#x2013;<lpage>1270</lpage>.</mixed-citation></ref>
<ref id="c40"><label>[40]</label><mixed-citation publication-type="journal"><string-name><given-names>S.</given-names> <surname>Moreno-Gamez</surname></string-name>, <string-name><given-names>A. L.</given-names> <surname>Hill</surname></string-name>, <string-name><given-names>D. I. S.</given-names> <surname>Rosenbloom</surname></string-name>, <string-name><given-names>D. A.</given-names> <surname>Petrov</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, and <string-name><given-names>P. S.</given-names> <surname>Pennings</surname></string-name>, <article-title>Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance</article-title>, <source>Proceedings of the National Academy of Sciences</source>, <volume>112</volume> (<year>2015</year>), pp. <fpage>E2874</fpage>&#x2013;<lpage>E2883</lpage>.</mixed-citation></ref>
<ref id="c41"><label>[41]</label><mixed-citation publication-type="journal"><string-name><given-names>D.</given-names> <surname>Nichol</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Jeavons</surname></string-name>, <string-name><given-names>A. G.</given-names> <surname>Fletcher</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Bonomo</surname></string-name>, <string-name><given-names>P. K.</given-names> <surname>Maini</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Paul</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Gatenby</surname></string-name>, <string-name><given-names>A. R.</given-names> <surname>Anderson</surname></string-name>, and <string-name><given-names>J. G.</given-names> <surname>Scott</surname></string-name>, <article-title>Steering evolution with sequential therapy to prevent the emergence of bacterial antibiotic resistance</article-title>, <source>PLOS Computational Biology</source>, <volume>11</volume> (<year>2015</year>), pp. <fpage>1</fpage>&#x2013;<lpage>19</lpage>.</mixed-citation></ref>
<ref id="c42"><label>[42]</label><mixed-citation publication-type="journal"><string-name><given-names>M. D.</given-names> <surname>Nicholson</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Antal</surname></string-name>, <article-title>Universal asymptotic clone size distribution for general population growth</article-title>, <source>Bull Math Biol</source>, <volume>78</volume> (<year>2016</year>), p. <fpage>2243</fpage>&#x2013;<lpage>2276</lpage>.</mixed-citation></ref>
<ref id="c43"><label>[43]</label><mixed-citation publication-type="journal"><string-name><given-names>M. A.</given-names> <surname>Nowak</surname></string-name>, <string-name><given-names>N. L.</given-names> <surname>Komarova</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Sengupta</surname></string-name>, <string-name><given-names>P. V.</given-names> <surname>Jallepalli</surname></string-name>, <string-name><given-names>I.-M.</given-names> <surname>Shih</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Vogelstein</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Lengauer</surname></string-name>, <article-title>The role of chromosomal instability in tumor initiation</article-title>, <source>Proceedings of the National Academy of Sciences</source>, <volume>99</volume> (<year>2002</year>), pp. <fpage>16226</fpage>&#x2013;<lpage>16231</lpage>.</mixed-citation></ref>
<ref id="c44"><label>[44]</label><mixed-citation publication-type="journal"><string-name><given-names>J. E.</given-names> <surname>Pearson</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Krapivsky</surname></string-name>, and <string-name><given-names>A. S.</given-names> <surname>Perelson</surname></string-name>, <article-title>Stochastic theory of early viral infection: Continuous versus burst production of virions</article-title>, <source>PLOS Computational Biology</source>, <volume>7</volume> (<year>2011</year>), pp. <fpage>1</fpage>&#x2013;<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c45"><label>[45]</label><mixed-citation publication-type="journal"><string-name><given-names>A. J.</given-names> <surname>Primeau</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Rendon</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Hedley</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Lilge</surname></string-name>, and <string-name><given-names>I. F.</given-names> <surname>Tannock</surname></string-name>, <article-title>The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors</article-title>, <source>Clinical Cancer Research</source>, <volume>11</volume> (<year>2005</year>), pp. <fpage>8782</fpage>&#x2013;<lpage>8788</lpage>.</mixed-citation></ref>
<ref id="c46"><label>[46]</label><mixed-citation publication-type="journal"><string-name><given-names>A. C.</given-names> <surname>Tadrowski</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Evans</surname></string-name>, and <string-name><given-names>B.</given-names> <surname>Waclaw</surname></string-name>, <article-title>Phenotypic Switching Can Speed up Microbial Evolution</article-title>, <source>Scientific Reports</source>, <volume>8</volume> (<year>2018</year>), p. <fpage>8941</fpage>.</mixed-citation></ref>
<ref id="c47"><label>[47]</label><mixed-citation publication-type="journal"><string-name><given-names>P. D.</given-names> <surname>Tamma</surname></string-name>, <string-name><given-names>S. E.</given-names> <surname>Cosgrove</surname></string-name>, and <string-name><given-names>L. L.</given-names> <surname>Maragakis</surname></string-name>, <article-title>Combination therapy for treatment of infections with gram-negative bacteria</article-title>, <source>Clinical Microbiology Reviews</source>, <volume>25</volume> (<year>2012</year>), pp. <fpage>450</fpage>&#x2013;<lpage>470</lpage>.</mixed-citation></ref>
<ref id="c48"><label>[48]</label><mixed-citation publication-type="journal"><string-name><given-names>A. J.</given-names> <surname>Tipping</surname></string-name>, <string-name><given-names>F. X.</given-names> <surname>Manon</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Lagarde</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Goldman</surname></string-name>, and <string-name><given-names>J. V.</given-names> <surname>Melo</surname></string-name>, <article-title>Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells</article-title>, <source>Blood</source>, <volume>98</volume> (<year>2001</year>), pp. <fpage>3864</fpage>&#x2013;<lpage>3867</lpage>.</mixed-citation></ref>
<ref id="c49"><label>[49]</label><mixed-citation publication-type="journal"><string-name><given-names>T. D.</given-names> <surname>Tlsty</surname></string-name>, <string-name><given-names>B. H.</given-names> <surname>Margolin</surname></string-name>, and <string-name><given-names>K.</given-names> <surname>Lum</surname></string-name>, <article-title>Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis</article-title>, <source>Proc Natl Acad Sci U S A</source>, <volume>86</volume> (<year>1989</year>), pp. <fpage>9441</fpage>&#x2013;<lpage>9445</lpage>.</mixed-citation></ref>
<ref id="c50"><label>[50]</label><mixed-citation publication-type="other"><string-name><given-names>C.</given-names> <surname>Tomasetti</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Vogelstein</surname></string-name>, and <string-name><given-names>G.</given-names> <surname>Parmigiani</surname></string-name>, <article-title>Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation</article-title>, <source>Proceedings of the National Academy of Sciences</source>, (<year>2013</year>).</mixed-citation></ref>
<ref id="c51"><label>[51]</label><mixed-citation publication-type="book"><string-name><given-names>R. S.</given-names> <surname>Varga</surname></string-name>, <source>Matrix Iterative Analysis</source>, <publisher-name>Prentice-Hall International</publisher-name>, <year>1962</year>.</mixed-citation></ref>
<ref id="c52"><label>[52]</label><mixed-citation publication-type="journal"><string-name><given-names>H.</given-names> <surname>Ward</surname></string-name>, <string-name><given-names>G. G.</given-names> <surname>Perron</surname></string-name>, and <string-name><given-names>R. C.</given-names> <surname>MacLean</surname></string-name>, <article-title>The cost of multiple drug resistance in Pseudomonas aeruginosa</article-title>, <source>Journal of Evolutionary Biology</source>, <volume>22</volume> (<year>2009</year>), pp. <fpage>997</fpage>&#x2013;<lpage>1003</lpage>.</mixed-citation></ref>
<ref id="c53"><label>[53]</label><mixed-citation publication-type="journal"><string-name><given-names>D. F.</given-names> <surname>Warner</surname></string-name> and <string-name><given-names>V.</given-names> <surname>Mizrahi</surname></string-name>, <source>Tuberculosis chemotherapy: The influence of bacillary stress and damage response pathways on drug efficacy</source>, <year>2006</year>.</mixed-citation></ref>
<ref id="c54"><label>[54]</label><mixed-citation publication-type="journal"><string-name><given-names>D. M.</given-names> <surname>Weinreich</surname></string-name>, <string-name><given-names>N. F.</given-names> <surname>Delaney</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>DePristo</surname></string-name>, and <string-name><given-names>D. L.</given-names> <surname>Hartl</surname></string-name>, <article-title>Darwinian evolution can follow only very few mutational paths to fitter proteins</article-title>, <source>Science</source>, <volume>312</volume> (<year>2006</year>), pp. <fpage>111</fpage>&#x2013;<lpage>114</lpage>.</mixed-citation></ref>
<ref id="c55"><label>[55]</label><mixed-citation publication-type="book"><string-name><given-names>D. B.</given-names> <surname>Weissman</surname></string-name>, <string-name><given-names>M. M.</given-names> <surname>Desai</surname></string-name>, <string-name><given-names>D. S.</given-names> <surname>Fisher</surname></string-name>, and <string-name><given-names>M. W.</given-names> <surname>Feldman</surname></string-name>, <chapter-title>The rate at which asexual populations cross fitness valleys</chapter-title>, <source>Theoretical Population Biology</source>, <volume>75</volume> (<year>2009</year>), pp. <fpage>286</fpage>&#x2013;<lpage>300</lpage>. <publisher-name>Sam Karlin: Special Issue</publisher-name>.</mixed-citation></ref>
<ref id="c56"><label>[56]</label><mixed-citation publication-type="journal"><string-name><given-names>R. D.</given-names> <surname>Wilkinson</surname></string-name> and <string-name><given-names>S.</given-names> <surname>Tavar&#x00E9;</surname></string-name>, <article-title>Estimating primate divergence times by using conditioned birth-and-death processes</article-title>, <source>Theoretical Population Biology</source>, <volume>75</volume> (<year>2009</year>), pp. <fpage>278</fpage>&#x2013;<lpage>285</lpage>. <person-group person-group-type="editor"><string-name><given-names>Sam</given-names> <surname>Karlin</surname></string-name></person-group>: Special Issue.</mixed-citation></ref>
<ref id="c57"><label>[57]</label><mixed-citation publication-type="journal"><string-name><given-names>M. J.</given-names> <surname>Williams</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Werner</surname></string-name>, <string-name><given-names>C. P.</given-names> <surname>Barnes</surname></string-name>, <string-name><given-names>T. A.</given-names> <surname>Graham</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Sottoriva</surname></string-name>, <article-title>Identification of neutral tumor evolution across cancer types</article-title>, <source>Nature Genetics</source>, <volume>48</volume> (<year>2016</year>), pp. <fpage>238</fpage>&#x2013;<lpage>244</lpage>.</mixed-citation></ref>
<ref id="c58"><label>[58]</label><mixed-citation publication-type="journal"><string-name><given-names>M.</given-names> <surname>Zagorski</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Burda</surname></string-name>, and <string-name><given-names>B.</given-names> <surname>Waclaw</surname></string-name>, <article-title>Beyond the hypercube: Evolutionary accessibility of fitness landscapes with realistic mutational networks</article-title>, <source>PLOS Computational Biology</source>, <volume>12</volume> (<year>2016</year>), pp. <fpage>1</fpage>&#x2013;<lpage>18</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>